<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Inf. Microbio.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Inf. Microbio.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2012.00048</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research Article</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Evolutionary blueprint for host- and niche-adaptation in <italic>Staphylococcus aureus</italic> clonal complex CC30</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>McGavin</surname> <given-names>Martin J.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Arsic</surname> <given-names>Benjamin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nickerson</surname> <given-names>Nicholas N.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Microbiology, Schulich School of Medicine and Dentistry, Siebens Drake Research Institute and Centre for Human Immunology, University of Western Ontario, London</institution> <country>ON, Canada</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Molecular and Cellular Biology, University of Guelph, Guelph</institution> <country>ON, Canada</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: David Heinrichs, University of Western Ontario, Canada</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Steven Gill, University of Rochester School of Medicine and Dentistry, USA; Jodi A. Lindsay, St George&#x00027;s University of London, UK</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Martin J. McGavin, Department of Microbiology, Schulich School of Medicine and Dentistry, and Centre for Human Immunology, Western University, London, ON N6A 5C1, Canada. e-mail: <email>martin.mcgavin&#x00040;schulich.uwo.ca</email></p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>04</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="collection">
<year>2012</year>
</pub-date>
<volume>2</volume>
<elocation-id>48</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>01</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>03</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2012 McGavin, Arsic and Nickerson.</copyright-statement>
<copyright-year>2012</copyright-year>
<license license-type="open-access" xlink:href="http://www.frontiersin.org/licenseagreement"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.</p>
</license>
</permissions>
<abstract><p><italic>Staphylococcus aureus</italic> clonal complex CC30 has caused infectious epidemics for more than 60 years, and, therefore, provides a model system to evaluate how evolution has influenced the disease potential of closely related strains. In previous multiple genome comparisons, phylogenetic analyses established three major branches that evolved from a common ancestor. Clade 1, comprised of historic pandemic phage type 80/81 methicillin susceptible <italic>S. aureus</italic> (MSSA), and Clade 2 comprised of contemporary community acquired methicillin resistant <italic>S. aureus</italic> (CA-MRSA) were hyper-virulent in murine infection models. Conversely, Clade 3 strains comprised of contemporary hospital associated MRSA (HA-MRSA) and clinical MSSA exhibited attenuated virulence, due to common single nucleotide polymorphisms (SNP&#x00027;s) that abrogate production of &#x003B1;-hemolysin Hla, and interfere with signaling of the accessory gene regulator <italic>agr</italic>. We have now completed additional <italic>in silico</italic> genome comparisons of 15 additional CC30 genomes in the public domain, to assess the hypothesis that Clade 3 has evolved to favor niche adaptation. In addition to SNP&#x00027;s that influence <italic>agr</italic> and <italic>hla</italic>, other common traits of Clade 3 include tryptophan auxotrophy due to a di-nucleotide deletion within <italic>trpD</italic>, a premature stop codon within <italic>isdH</italic> encoding an immunogenic cell surface protein involved in iron acquisition, loss of a genomic toxin&#x02013;antitoxin (TA) addiction module, acquisition of <italic>S. aureus</italic> pathogenicity islands SaPI4, and SaPI2 encoding toxic shock syndrome toxin <italic>tst</italic>, and increased copy number of insertion sequence ISSau2, which appears to target transcription terminators. Compared to other Clade 3 MSSA, <italic>S. aureus</italic> MN8, which is associated with Staphylococcal toxic shock syndrome, exhibited a unique ISSau2 insertion, and enhanced production of toxic shock syndrome toxin encoded by SaPI2. Cumulatively, our data support the notion that Clade 3 strains are following an evolutionary blueprint toward niche-adaptation.</p></abstract>
<kwd-group>
<kwd><italic>Staphylococcus aureus</italic></kwd>
<kwd>evolution</kwd>
<kwd>pseudogene</kwd>
<kwd>pathogenicity island</kwd>
<kwd>insertion sequence</kwd>
<kwd>toxin-antitoxin addiction module</kwd>
<kwd>pathoadaptation</kwd>
<kwd>virulence</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="91"/>
<page-count count="13"/>
<word-count count="11511"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="introduction" id="s1">
<title>Introduction</title>
<p>Society has become imbued with the Superbug label to define strains of antibiotic resistant bacteria that cause hospital-associated outbreaks of infection (Foster, <xref ref-type="bibr" rid="B25">2004</xref>; Abbott, <xref ref-type="bibr" rid="B1">2005</xref>; Brazier, <xref ref-type="bibr" rid="B5">2008</xref>; Guo et al., <xref ref-type="bibr" rid="B33">2011</xref>). This term, denoting the sudden emergence and spread of new antibiotic resistant strains, could also be applied to an historic global pandemic caused by a penicillin-resistant <italic>S. aureus</italic> clone known as phage type PT80/81, which emerged in Australia, Great Britain, and North America in the early 1950&#x00027;s (Rountree and Beard, <xref ref-type="bibr" rid="B75">1958</xref>; Williams et al., <xref ref-type="bibr" rid="B89">1959</xref>; Wormald, <xref ref-type="bibr" rid="B90">1961</xref>; Tanimoto, <xref ref-type="bibr" rid="B84">1962</xref>). The initial outbreaks occurred in hospitals, especially among newborns and nursing mothers, but quickly spread to the wider community, causing unusually severe invasive skin infections, and fatal sepsis or necrotizing pneumonia in young and healthy individuals (Hassall and Rountree, <xref ref-type="bibr" rid="B35">1959</xref>). Although the pandemic dissipated after 10 years (&#x0223C;1953&#x02013;1963), concomitant with the introduction of methicillin, genetically related contemporary strains are prominent in both the community and health-care settings. These consist of clinical methicillin susceptible <italic>S. aureus</italic> (MSSA), the epidemic EMRSA-16 lineage of hospital associated MRSA (HA-MRSA) which has the Type II Staphylococcal cassette chromosome SCC<italic>mec</italic> element, and the hyper-virulent Southwest Pacific (SWP) clone of community associated MRSA (CA-MRSA) which, like other unrelated CA-MRSA, has Type IV SCC<italic>mec</italic>. All of these strains belong to clonal complex CC30 as determined by multi locus sequence typing (MLST) analysis (Robinson et al., <xref ref-type="bibr" rid="B74">2005</xref>).</p>
<p>To better understand the evolutionary development of CC30, we recently employed comparative genome sequencing to evaluate nine CC30 strains (DeLeo et al., <xref ref-type="bibr" rid="B18">2011</xref>), including the reference genome of MRSA 252, representing the EMRSA-16 clone of HA-MRSA (Holden et al., <xref ref-type="bibr" rid="B37">2004</xref>; Lindsay and Holden, <xref ref-type="bibr" rid="B52">2004</xref>). Phylogenetic analyses based on a contiguous 1.4 Mb region of each genome, or with concatenated nucleotide segments, supported the existence of three major branches that evolved from a common ancestor. Clade I consists of the historic PT80/81 pandemic. This clonal type is typically ST30<italic>spa</italic>43, as determined by MLST and staphylococcal Protein A (<italic>spa</italic>) gene typing, and possesses the Panton Valentin Leukotoxin (PVL), that is also characteristic of contemporary CA-MRSA, including the SWP clone, which is ST30<italic>spa</italic>19 and comprises Clade 2. Although temporally separated by nearly 50 years, Clades 1 and 2 share a number of common traits, which in addition to PVL, include abundant production of &#x003B1;-hemolysin Hla, elevated transcription of RNAIII encoded by the accessory gene regulator <italic>agr</italic> locus, and a hypervirulent trait in murine infection models (DeLeo et al., <xref ref-type="bibr" rid="B18">2011</xref>).</p>
<p>Clade 3 is comprised of the EMRSA-16 clone of HA-MRSA, which is typically ST36<italic>spa</italic>16, and contemporary clinical methicillin susceptible <italic>S. aureus</italic>, which are often ST30<italic>spa</italic>33. Although Clade 3 strains exhibited attenuated virulence in murine infection models relative to Clades 1 and 2, these are still associated with a high burden of disease. EMRSA-16, which is known in the United States as USA200, has become one of the most successful HA-MRSA clones (Cox et al., <xref ref-type="bibr" rid="B14">1995</xref>; Enright et al., <xref ref-type="bibr" rid="B21">2000</xref>; Johnson et al., <xref ref-type="bibr" rid="B40">2001</xref>; McDougal et al., <xref ref-type="bibr" rid="B58">2003</xref>; Seybold et al., <xref ref-type="bibr" rid="B81">2006</xref>; Fowler et al., <xref ref-type="bibr" rid="B26">2007</xref>). Others defined an association of CC30 MSSA, frequently ST30<italic>spa33</italic>, with bacteremia, infective endocarditis, and osteomyelitis (Cassat et al., <xref ref-type="bibr" rid="B8">2005</xref>; Fowler et al., <xref ref-type="bibr" rid="B26">2007</xref>; Nienaber et al., <xref ref-type="bibr" rid="B65">2011</xref>). Staphylococcal toxic shock syndrome, which emerged in the late 1970&#x00027;s (Altemeier et al., <xref ref-type="bibr" rid="B2">1981</xref>), is also associated with CC30, and the <italic>tst</italic> gene encoding toxic shock syndrome toxin has a strong clonal association with CC30 nasal carriage and bacteremia isolates (Holtfreter et al., <xref ref-type="bibr" rid="B38">2007</xref>). MSSA that resemble the EMRSA-16 clone were also commonly associated with asymptomatic nasal carriage in the United States (Kuehnert et al., <xref ref-type="bibr" rid="B45">2006</xref>), and other studies concur that CC30 is a major clonal complex associated with nasal carriage (Feil et al., <xref ref-type="bibr" rid="B24">2003</xref>; Melles et al., <xref ref-type="bibr" rid="B60">2004</xref>; Kuehnert et al., <xref ref-type="bibr" rid="B45">2006</xref>; Fowler et al., <xref ref-type="bibr" rid="B26">2007</xref>; Ko et al., <xref ref-type="bibr" rid="B43">2008</xref>; Melles et al., <xref ref-type="bibr" rid="B61">2008</xref>). Therefore, although Clade 3 exhibits attenuated virulence in murine infection models, we proposed that the high burden of disease associated with these hospital associated strains could be due to the high incidence of colonization, affording more opportunity to cause infection.</p>
<p>Several observations support the contention that Clade 3 evolved to favor enhanced colonization, at the expense of attenuated virulence. Foremost, the genome of MRSA 252 has the highest content of pseudogenes compared to other <italic>S. aureus</italic> genomes (Holden et al., <xref ref-type="bibr" rid="B37">2004</xref>), and gene decay is a major force in niche-adaptation of microbial pathogens (Moran and Plague, <xref ref-type="bibr" rid="B63">2004</xref>). Most notable among the pseudogenes was a CAG to TAG transition at Gln<sub>113</sub> of <italic>hla</italic> encoding &#x003B1;-hemolysin (Hla), which is a major lethal virulence factor of CA-MRSA (Bubeck Wardenburg et al., <xref ref-type="bibr" rid="B6">2007</xref>). This mutation, which creates a premature stop codon, is broadly disseminated in Clade 3, including HA-MRSA and clinical MSSA (DeLeo et al., <xref ref-type="bibr" rid="B18">2011</xref>). Clade 3 strains also possessed a single nucleotide polymorphism (SNP) in <italic>agrC</italic> of the accessory gene regulator <italic>agr</italic> locus, causing a Gly<sub>55</sub> &#x0003E;Arg change in the AgrC sensor protein, leading to attenuated transcription of the RNAIII product that is needed to produce secreted virulence factors (DeLeo et al., <xref ref-type="bibr" rid="B18">2011</xref>). Consequently, attenuated transcription of <italic>agr</italic>, and inability to produce Hla contribute to the attenuated virulence of Clade 3.</p>
<p>Other defining traits of genomes that are in transition toward niche adaptation include acquisition of mobile genetic elements, and amplification of insertion sequence (IS) elements (Moran and Plague, <xref ref-type="bibr" rid="B63">2004</xref>). However, a common limitation of conducting multiple genome comparisons by mapping short sequence reads from multiple strains on to a known reference genome is that it may not detect large insertions or deletions that differentiate one or more strains from the reference genome. Accordingly, although <italic>tst</italic> encoding toxic shock syndrome toxin is associated with different <italic>S. aureus</italic> pathogenicity island (SaPI) structures, and has a strong clonal association with CC30, <italic>tst</italic> was not present in the MRSA 252 reference genome, and we failed to identify the relevant SaPI through multiple genome comparisons. Herein, we present a detailed analysis of the hypothesis that Clade 3 strains have evolved in favor of niche adaptation, by conducting <italic>in silico</italic> comparisons of 15 additional CC30 genomes that are available in the public domain. Our analysis of pseudogenes, SaPI and IS elements, and gene deletion events, support the hypothesis that Clade 3 is following an evolutionary blueprint towards host- and niche-adaptation.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Bacterial strains and growth conditions</title>
<p>A description of CC30 strains that were used in this study for analysis of secreted proteins and PCR assays is provided in Table <xref ref-type="table" rid="T1">1</xref>. In addition, <italic>S. aureus</italic> RN4220 was obtained from Richard Novick (Novick, <xref ref-type="bibr" rid="B66">1991</xref>). When needed for production of secreted proteins, cultures were grown overnight in tryptic soy broth (TSB; Difco) supplemented with 0.25% glucose, then sub-cultured into 25 ml of fresh TSB in a 125 ml Erlenmeyer flask to an initial optical density of 0.01 (OD<sub>600</sub> &#x0003D; 0.01), and grown for 18 h at 37&#x000B0;C on an orbital shaker at 150 rpm. To assess <italic>yefM-yoeB</italic> addiction module function, cells were grown on brain heart infusion (BHI) agar supplemented with 10 &#x003BC;g/ml erythromycin for plasmid maintenance, and 5 &#x003BC;m cadmium where indicated for induction of the P<sub><italic>cad</italic></sub> promoter.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>Strains used in this study</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left"><bold>Strain</bold></th>
<th align="left"><bold>Description</bold></th>
<th align="left"><bold>Clade<xref ref-type="table-fn" rid="TN1"><sup><italic>a</italic></sup></xref></bold></th>
<th align="left"><bold>Year</bold></th>
<th align="left"><bold>MLST</bold></th>
<th align="left"><bold>Spa type<xref ref-type="table-fn" rid="TN2"><sup><italic>b</italic></sup></xref></bold></th>
<th align="left"><bold>Source/Reference</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">ATCC 12598; Cowan</td>
<td align="left">Pre-pandemic; septic arthritis</td>
<td align="left">ND</td>
<td align="left">1935</td>
<td align="left">ST30</td>
<td align="left">99/t076</td>
<td align="left">ATCC</td>
</tr>
<tr>
<td align="left">NRS204; Florey</td>
<td align="left">Pre-pandemic</td>
<td align="left">ND</td>
<td align="left">1940</td>
<td align="left">ST30</td>
<td align="left">251/t318</td>
<td align="left">Barry Kreiswirth</td>
</tr>
<tr>
<td align="left">ATCC 25923; Seattle 1945</td>
<td align="left">Pre-pandemic</td>
<td align="left">ND</td>
<td align="left">1945</td>
<td align="left">ST243<xref ref-type="table-fn" rid="TN3"><sup><italic>c</italic></sup></xref></td>
<td align="left">43/t021</td>
<td align="left">ATCC</td>
</tr>
<tr>
<td align="left">M809</td>
<td align="left">PT80/81 pandemic</td>
<td align="left">1</td>
<td align="left">1961</td>
<td align="left">ST30</td>
<td align="left">43/t021</td>
<td align="left">Robinson et al., <xref ref-type="bibr" rid="B74">2005</xref></td>
</tr>
<tr>
<td align="left">M1015</td>
<td align="left">PT80/81 pandemic</td>
<td align="left">1</td>
<td align="left">1962</td>
<td align="left">ST30</td>
<td align="left">43/t021</td>
<td align="left">Robinson et al., <xref ref-type="bibr" rid="B74">2005</xref></td>
</tr>
<tr>
<td align="left">WBG10049</td>
<td align="left">CA-MRSA; Southwest Pacific Clone</td>
<td align="left">2</td>
<td align="left">1999</td>
<td align="left">ST30</td>
<td align="left">19/t019</td>
<td align="left">Robinson et al., <xref ref-type="bibr" rid="B74">2005</xref></td>
</tr>
<tr>
<td align="left">MN8</td>
<td align="left">Contemporary MSSA; menstrual toxic shock</td>
<td align="left">3</td>
<td align="left">1980</td>
<td align="left">ST30</td>
<td align="left">33/t012</td>
<td align="left">Schlievert and Blomster, <xref ref-type="bibr" rid="B78">1983</xref></td>
</tr>
<tr>
<td align="left">L516</td>
<td align="left">Contemporary MSSA; infective endocarditis</td>
<td align="left">3</td>
<td align="left">1994</td>
<td align="left">ST30</td>
<td align="left">33/t012</td>
<td align="left">Lindsay Nicolle, University of Manitoba</td>
</tr>
<tr>
<td align="left">L528</td>
<td align="left">Contemporary MSSA; bacteremia</td>
<td align="left">3</td>
<td align="left">1994</td>
<td align="left">ST30</td>
<td align="left">33/t012</td>
<td align="left">Lindsay Nicolle, University of Manitoba</td>
</tr>
<tr>
<td align="left">UAMS-1</td>
<td align="left">Contemporary MSSA; osteomyelitis</td>
<td align="left">3</td>
<td align="left">1995</td>
<td align="left">ST30</td>
<td align="left">33/t012</td>
<td align="left">Gillaspy et al., <xref ref-type="bibr" rid="B31">1995</xref></td>
</tr>
<tr>
<td align="left">PM7</td>
<td align="left">HA-MRSA; EMRSA-16</td>
<td align="left">3</td>
<td align="left">2002</td>
<td align="left">ST36<xref ref-type="table-fn" rid="TN3"><sup><italic>c</italic></sup></xref></td>
<td align="left">16/t018</td>
<td align="left">Moore and Lindsay, <xref ref-type="bibr" rid="B62">2002</xref></td>
</tr>
<tr>
<td align="left">PM64</td>
<td align="left">HA-MRSA; EMRSA-16</td>
<td align="left">3</td>
<td align="left">2002</td>
<td align="left">ST36<xref ref-type="table-fn" rid="TN3"><sup><italic>c</italic></sup></xref></td>
<td align="left">16/t018</td>
<td align="left">Moore and Lindsay, <xref ref-type="bibr" rid="B62">2002</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>a</label>
<p><italic>ND, not determined.</italic></p></fn>
<fn id="TN2">
<label>b</label>
<p><italic>Provided in both Kreiswirth [Shopsin et al. (<xref ref-type="bibr" rid="B82">1999</xref>)] and Ridom (spa.ridom.de) nomenclature.</italic></p></fn>
<fn id="TN3">
<label>c</label>
<p><italic>Single-locus MLST variants of ST30.</italic></p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Genome comparisons</title>
<p>Table <xref ref-type="table" rid="T2">2</xref> provides information on 19 CC30 strains for which genome sequence data are available in the public domain. Of these, MRSA 252 (Holden et al., <xref ref-type="bibr" rid="B37">2004</xref>) was used as a reference genome for SNP analysis of multiple CC30 genomes (DeLeo et al., <xref ref-type="bibr" rid="B18">2011</xref>), which in addition to MRSA 252 included three other strains listed in Table <xref ref-type="table" rid="T2">2</xref>; M1015, WBG10049, and MN8. Of the genomes referred to in Table <xref ref-type="table" rid="T2">2</xref>, those of TCH60 and MRSA 252 are assembled as a single nucleotide sequence, and all others are in assembly phase. Sequence coverage ranged from 10.5&#x000D7; (WW2703/97) to 36&#x000D7; (MN8). Unpublished genome data from strain UAMS-1 was provided by Dr.&#x00027;s Mark Smeltzer and Jacques Schrenzel. The Basic Local Alignment Search Tool (BLAST) was used to query these genomes with segments of the annotated genome of MRSA 252 (Holden et al., <xref ref-type="bibr" rid="B37">2004</xref>). Query segments were selected on the basis of SNP&#x00027;s, indels, or mobile genetic elements previously noted in the genome of MRSA 252, that were of discriminatory value in assigning evolutionary variants of CC30 (DeLeo et al., <xref ref-type="bibr" rid="B18">2011</xref>). Genomes were also queried with the integrase (<italic>int</italic>) gene of known <italic>S. aureus</italic> pathogenicity islands (SaPI), to identify contigs that contained SaPI structures. Genome segments containing SaPI&#x00027;s and other mobile genetic elements or genes of interest were analyzed using MacVector version 7.2.3 software (Accelerys).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p><bold>Summary of CC30 strains and genotypic data</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="18"><bold>CLADE:</bold></th>
</tr>
<tr>
<th align="left"></th>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th align="center" colspan="5"><bold>ISSau2<xref ref-type="table-fn" rid="TN8"><sup><italic>e</italic></sup></xref></bold></th>
</tr>
<tr>
<th align="left"><bold>Isolate<xref ref-type="table-fn" rid="TN4"><sup><italic>a</italic></sup></xref></bold></th>
<th align="left"><bold>PRJNA<xref ref-type="table-fn" rid="TN5"><sup><italic>b</italic></sup></xref></bold></th>
<th align="left"><bold>Year</bold></th>
<th align="left"><bold>Country</bold></th>
<th align="left"><bold>Genotype</bold></th>
<th align="left"><bold>SCC<italic>mec</italic></bold></th>
<th align="left"><bold>PVL<xref ref-type="table-fn" rid="TN7"><sup><italic>d</italic></sup></xref></bold></th>
<th align="left"><bold><italic>agrC</italic></bold></th>
<th align="left"><bold><italic>hla</italic></bold></th>
<th align="left"><bold><italic>isdH</italic></bold></th>
<th align="left"><bold><italic>trpG</italic></bold></th>
<th align="left"><bold>TA-module</bold></th>
<th align="left"><bold>SaPI</bold></th>
<th align="left"><bold><italic>trpS</italic></bold></th>
<th align="left"><bold><italic>rRNA-3</italic></bold></th>
<th align="left"><bold><italic>rplQ</italic></bold></th>
<th align="left"><bold><italic>sbcC</italic><xref ref-type="table-fn" rid="TN9"><sup><italic>f</italic></sup></xref></bold></th>
<th align="left"><bold><italic>saeRS</italic></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="18"><bold>CLADE 1:</bold></td>
</tr>
<tr>
<td align="left">55/2053</td>
<td align="left">55909</td>
<td align="left">1955</td>
<td align="left">England</td>
<td align="left">ST30<italic>spa</italic>43</td>
<td align="left">MSSA</td>
<td align="left">P</td>
<td align="left">Gly<sub>55</sub></td>
<td align="left">CAG<sub><italic>Gln</italic></sub></td>
<td align="left">CAA<sub><italic>Gln</italic></sub></td>
<td align="left">6TG</td>
<td align="left">P</td>
<td align="left">SaPI1</td>
<td align="left">P</td>
<td/>
<td align="left">A</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">58&#x02013;424</td>
<td align="left">47005</td>
<td align="left">1958</td>
<td align="left">GA, USA</td>
<td align="left">ST30<italic>spa</italic>43</td>
<td align="left">MSSA</td>
<td align="left">P</td>
<td align="left">Gly<sub>55</sub></td>
<td align="left">CAG<sub><italic>Gln</italic></sub></td>
<td align="left">CAA<sub><italic>Gln</italic></sub></td>
<td align="left">6TG</td>
<td align="left">P</td>
<td align="left">SaPI1</td>
<td align="left">P</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">E1410</td>
<td align="left">55915</td>
<td align="left">1962</td>
<td align="left">Denmark</td>
<td align="left">ST30<italic>spa</italic>43</td>
<td align="left">MSSA</td>
<td align="left">A</td>
<td align="left">Gly<sub>55</sub></td>
<td align="left">CAG<sub><italic>Gln</italic></sub></td>
<td align="left">CAA<sub><italic>Gln</italic></sub></td>
<td align="left">6TG</td>
<td align="left">P</td>
<td align="left">SaPI1</td>
<td align="left">P</td>
<td/>
<td align="left">A</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">M1015<xref ref-type="table-fn" rid="TN6"><sup><italic>c</italic></sup></xref></td>
<td align="left">47009</td>
<td align="left">1962</td>
<td align="left">Australia</td>
<td align="left">ST30<italic>spa</italic>43</td>
<td align="left">MSSA</td>
<td align="left">P</td>
<td align="left">Gly<sub>55</sub></td>
<td align="left">CAG<sub><italic>Gln</italic></sub></td>
<td align="left">CAA<sub><italic>Gln</italic></sub></td>
<td align="left">6TG</td>
<td align="left">P</td>
<td align="left">SaPI1</td>
<td align="left">P</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">M876</td>
<td align="left">55917</td>
<td align="left">1961</td>
<td align="left">Australia</td>
<td align="left">ST30<italic>spa</italic>43</td>
<td align="left">MSSA</td>
<td align="left">P</td>
<td align="left">Gly<sub>55</sub></td>
<td align="left">CAG<sub><italic>Gln</italic></sub></td>
<td align="left">CAA<sub><italic>Gln</italic></sub></td>
<td align="left">6TG</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left">M809</td>
<td align="left">47007</td>
<td align="left">1961</td>
<td align="left">Australia</td>
<td align="left">ST431<italic>spa</italic>43</td>
<td align="left">MSSA</td>
<td align="left">P</td>
<td align="left">Gly<sub>55</sub></td>
<td align="left">CAG<sub><italic>Gln</italic></sub></td>
<td align="left">CAA<sub><italic>Gln</italic></sub></td>
<td align="left">6TG</td>
<td align="left">P</td>
<td align="left">SaPI1</td>
<td align="left">P</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">M899</td>
<td align="left">42993</td>
<td align="left">1961</td>
<td align="left">Australia</td>
<td align="left">ST30<italic>spa</italic>43</td>
<td align="left">MSSA</td>
<td align="left">P</td>
<td align="left">Gly<sub>55</sub></td>
<td align="left">CAG<sub><italic>Gln</italic></sub></td>
<td align="left">CAA<sub><italic>Gln</italic></sub></td>
<td align="left">6TG</td>
<td align="left">P</td>
<td align="left">SaPI1</td>
<td align="left">P</td>
<td/>
<td align="left">A</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">65&#x02013;1322</td>
<td align="left">55911</td>
<td align="left">1965</td>
<td align="left">WV, USA</td>
<td align="left">ST30<italic>spa</italic>43</td>
<td align="left">MSSA</td>
<td align="left">P</td>
<td align="left">Gly<sub>55</sub></td>
<td align="left">CAG<sub><italic>Gln</italic></sub></td>
<td align="left">CAA<sub><italic>Gln</italic></sub></td>
<td align="left">6TG</td>
<td align="left">P</td>
<td align="left">SaPI1</td>
<td align="left">P</td>
<td/>
<td align="left">A</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">68&#x02013;397</td>
<td align="left">55913</td>
<td align="left">1968</td>
<td align="left">TX, USA</td>
<td align="left">ST30</td>
<td align="left">MSSA</td>
<td align="left">P</td>
<td align="left">Gly<sub>55</sub></td>
<td align="left">CAG<sub><italic>Gln</italic></sub></td>
<td align="left">CAA<sub><italic>Gln</italic></sub></td>
<td align="left">6TG</td>
<td align="left">P</td>
<td align="left">SaPI1</td>
<td align="left">P</td>
<td/>
<td align="left">A</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">C101</td>
<td align="left">43001</td>
<td align="left">1997</td>
<td align="left">England</td>
<td align="left">ST30<italic>spa</italic>43</td>
<td align="left">MSSA</td>
<td align="left">A</td>
<td align="left">Gly<sub>55</sub></td>
<td align="left">CAG<sub><italic>Gln</italic></sub></td>
<td align="left">CAA<sub><italic>Gln</italic></sub></td>
<td align="left">6TG</td>
<td align="left">P</td>
<td align="left">SaPI1</td>
<td align="left">P</td>
<td/>
<td align="left">A</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left" colspan="18"><bold>CLADE 2:</bold></td>
</tr>
<tr>
<td align="left">WBG10049<xref ref-type="table-fn" rid="TN6"><sup><italic>c</italic></sup></xref></td>
<td align="left">42991</td>
<td align="left">1999</td>
<td align="left">Australia</td>
<td align="left">ST30<italic>spa</italic>19</td>
<td align="left">IV</td>
<td align="left">P</td>
<td align="left">Gly<sub>55</sub></td>
<td align="left">CAG<sub><italic>Gln</italic></sub></td>
<td align="left">CAA<sub><italic>Gln</italic></sub></td>
<td align="left">6TG</td>
<td align="left">P</td>
<td align="left">SaPI1</td>
<td align="left">P</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">TCH60</td>
<td align="left">CP002110</td>
<td/>
<td align="left">TX, USA</td>
<td align="left">ST30<italic>spa</italic>19</td>
<td align="left">IV</td>
<td align="left">P</td>
<td align="left">Gly<sub>55</sub></td>
<td align="left">CAG<sub><italic>Gln</italic></sub></td>
<td align="left">CAA<sub><italic>Gln</italic></sub></td>
<td align="left">6TG</td>
<td align="left">P</td>
<td align="left">SaPI1</td>
<td align="left">P</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left" colspan="18"><bold>CLADE 3:</bold></td>
</tr>
<tr>
<td align="left">MN8<xref ref-type="table-fn" rid="TN6"><sup><italic>c</italic></sup></xref></td>
<td align="left">59529</td>
<td align="left">1980</td>
<td align="left">MN, USA</td>
<td align="left">ST30<italic>spa</italic>33</td>
<td align="left">MSSA</td>
<td align="left">A</td>
<td align="left">Arg<sub>55</sub></td>
<td align="left">TAG<sup>&#x0002A;</sup></td>
<td align="left">TAA<sup>&#x0002A;</sup></td>
<td align="left">5TG</td>
<td align="left">A</td>
<td align="left">SaPI2, SaPI4</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">P</td>
</tr>
<tr>
<td align="left">UAMS-1</td>
<td/>
<td align="left">1995</td>
<td align="left">AR, USA</td>
<td align="left">ST30<italic>spa</italic>33</td>
<td align="left">MSSA</td>
<td align="left">A</td>
<td align="left">Arg<sub>55</sub></td>
<td align="left">TAG<sup>&#x0002A;</sup></td>
<td align="left">TAA<sup>&#x0002A;</sup></td>
<td align="left">5TG</td>
<td align="left">A</td>
<td align="left">SaPI2, SaPI4</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">Btn1260</td>
<td align="left">42987</td>
<td align="left">1999</td>
<td align="left">England</td>
<td align="left">ST30<italic>spa</italic>33</td>
<td align="left">MSSA</td>
<td align="left">A</td>
<td align="left">Arg<sub>55</sub></td>
<td align="left">TAG<sup>&#x0002A;</sup></td>
<td align="left">TAA<sup>&#x0002A;</sup></td>
<td align="left">5TG</td>
<td align="left">A</td>
<td align="left">SaPI2, SaPI4</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">MRSA 252<xref ref-type="table-fn" rid="TN6"><sup><italic>c</italic></sup></xref></td>
<td align="left">57839</td>
<td align="left">1990&#x00027;s</td>
<td align="left">England</td>
<td align="left">ST36<italic>spa</italic>16</td>
<td align="left">II</td>
<td align="left">A</td>
<td align="left">Arg<sub>55</sub></td>
<td align="left">TAG<sup>&#x0002A;</sup></td>
<td align="left">TAA<sup>&#x0002A;</sup></td>
<td align="left">5TG</td>
<td align="left">A</td>
<td align="left">SaPI4</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">P</td>
<td align="left">P</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">EMRSA-16</td>
<td align="left">48295</td>
<td align="left">1990&#x00027;s</td>
<td align="left">England</td>
<td align="left">ST36<italic>spa</italic>16</td>
<td align="left">II</td>
<td align="left">A</td>
<td align="left">Arg<sub>55</sub></td>
<td align="left">TAG<sup>&#x0002A;</sup></td>
<td align="left">TAA<sup>&#x0002A;</sup></td>
<td align="left">5TG</td>
<td align="left">A</td>
<td align="left">SaPI2, SaPI4</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">P</td>
<td align="left">P</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">A017934/97</td>
<td align="left">43393</td>
<td align="left">1997</td>
<td align="left">Sweden</td>
<td align="left">ST30<italic>spa</italic>43</td>
<td align="left">IV</td>
<td align="left">A</td>
<td align="left">Arg<sub>55</sub></td>
<td align="left">TAG<sup>&#x0002A;</sup></td>
<td align="left">TAA<sup>&#x0002A;</sup></td>
<td align="left">5TG</td>
<td align="left">A</td>
<td align="left">SaPI2, SaPI4</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">WW2703/97</td>
<td align="left">42989</td>
<td align="left">1997</td>
<td align="left">Germany</td>
<td align="left">ST30<italic>spa</italic>16</td>
<td align="left">IV</td>
<td align="left">A</td>
<td align="left">Arg<sub>55</sub></td>
<td align="left">TAG<sup>&#x0002A;</sup></td>
<td align="left">TAA<sup>&#x0002A;</sup></td>
<td align="left">5TG</td>
<td align="left">A</td>
<td align="left">SaPI4</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">P</td>
<td align="left">A</td>
<td align="left">A</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN4">
<label>a</label>
<p><italic>Data for year, country, MLST, spa, SCCmec and PVL derived from [Robinson et al. (<xref ref-type="bibr" rid="B74">2005</xref>)], with exception of TCH60, MN8, and UAMS-1.</italic></p></fn>
<fn id="TN5">
<label>b</label>
<p><italic>Public domain whole genome sequencing project nucleic acid sequence accession number.</italic></p></fn>
<fn id="TN6">
<label>c</label>
<p><italic>Included in genome comparisons conducted by SOLiD 3 sequencing and SNP analysis [DeLeo et al. (<xref ref-type="bibr" rid="B18">2011</xref>)].</italic></p></fn>
<fn id="TN7">
<label>d</label>
<p><italic>Defined as present (P) or absent (A), as also for toxin-antitoxin module (TA) and SaPI elements.</italic></p></fn>
<fn id="TN8">
<label>e</label>
<p><italic>ISSau2 insertion sites defined in Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F3">3</xref>.</italic></p></fn>
<fn id="TN9">
<label>f</label>
<p><italic>Same distribution profile for ISSau2 insertions at sbcC, rRNA-1 and rRNA-2.</italic></p></fn>
</table-wrap-foot>
</table-wrap>
<p>PCR was employed to assess presence or absence of two unique ISSau2 insertions in different strains. One insertion adjacent to the <italic>saeRS</italic> regulatory locus was detected with primers SAR0758_For 5&#x02032;-CAATATCGAACGCCACTTGAGC-3&#x02032;, and SAR0757_Rev 5&#x02032;-CAGCTATGATTGCAGGTTACCAGC-3&#x02032;. Another insertion adjacent to the 5S-rRNA-3 site (Figure <xref ref-type="fig" rid="F1">1</xref>) was detected with primers SAR2148_For 5&#x02032;-TTTCCCTCAACGTCCAGGTGC-3&#x02032; and 5S-rRNA-Rev 5&#x02032;-GCCGAACACAGAAGTTAAGCTCC-3&#x02032;. PCR was conducted with Roche AmpliTaq Gold DNA polymerase.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>SaPI and ISSau2 distribution in CC30.</bold> The location of each element is mapped on the reference genome of MRSA 252 [Holden et al. (<xref ref-type="bibr" rid="B37">2004</xref>)]. SaPIs are indicated by colored bars, on the circular blue genome, and are labeled on the interior of the circular genome. SaPI2 and SaPI4 (yellow) are unique to Clade 3. SaPI1 (light green) is present in PT80/81 (Clade 1) and ST30<italic>spa19</italic> CA-MRSA (Clade 2). SaPI3 and SaPIbov (red) are not in CC30, but their location is shown for reference, based on location of <italic>attS</italic> sites. ISSau2 insertions, indicated by colored lollipops above the circular genome, are named after the gene that is adjacent to each insertion. Three different 16S-23S-5S-rRNA loci are abbreviated as 5S-rRNA-1, 5S-rRNA-2, and 5S-rRNA-3.</p></caption>
<graphic xlink:href="fcimb-02-00048-g0001.tif"/>
</fig>
</sec>
<sec>
<title>Analysis of secreted proteins</title>
<p>Isolates representing different CC30 genotypes were cultured for 18 h in TSB, after which proteins in the cell-free culture supernatant were precipitated with trichloroacetic acid, and subjected to SDS-PAGE as described previously (Nickerson et al., <xref ref-type="bibr" rid="B64">2010</xref>). For detection of Hla, Western blot assays were conducted with PVDF membrane (Pall Corporation), and rabbit anti-Staphylococcal &#x003B1;-toxin primary antibody (Sigma). The secondary antibody was donkey anti-rabbit IgG IR800 conjugate (Rockland Immunochemicals Inc.), and blots were visualized on an Odyssey Infrared Imager from LiCor Biosciences.</p>
<p>Identification of Coomassie-Blue stained proteins was conducted at the London Regional Proteomics Centre at the University of Western Ontario. Protein bands were excised using an Ettan&#x02122; Spot Picker, and processed for mass spectrometry using a Waters MASSPrep Automated Digestor as described (Gyenis et al., <xref ref-type="bibr" rid="B34">2011</xref>). Processed samples were spotted on MALDI plates and analyzed on an Applied Biosystems 4700 Proteomics Analyzer. Data were acquired and processed using 4000 Series Explorer and Data Explorer (Applied Biosystems), and the peptide fingerprints were compared to the NCBInr database for Gram-positive bacteria, using the MASCOT search engine.</p>
</sec>
<sec>
<title>Cloning and expression of <italic>yefM-YoeB</italic> toxin&#x02013;antitoxin TA-module</title>
<p>Gene segments were amplified by PCR, and cloned in pCN51 (Charpentier et al., <xref ref-type="bibr" rid="B9">2004</xref>), for expression of the <italic>yefM-yoeB</italic> antitoxin-toxin genes together, or <italic>yoeB</italic> toxin on its own, from the cadmium inducible P<sub><italic>cad</italic></sub> promoter. PCR was conducted using template DNA from <italic>S. aureus</italic> strain M1015, with primers YefM_For 5&#x02032;-cgc<bold><italic>ggatcc</italic></bold>gttaactaattaaCAA<italic>AGGAGG</italic>GTTTATATGATTATC-3&#x02032;, and YoeB_Rev 5&#x02032;-tt<bold><italic>ggcgcgcc</italic></bold>TTAATCATAATGTGACCATGCCG-3&#x02032;, generating a 538 nt product containing <italic>yefM-yoeB</italic>. The lower case nucleotides incorporate <italic>BamHI</italic> (<bold><italic>ggatcc</italic></bold>) or <italic>AscI</italic> (<bold><italic>ggcgcgcc</italic></bold>) restriction sites, and in YefM_For also add TAA stop codons in all three open reading frames prior to the <italic>AGGAGG</italic> ribosome binding site of <italic>yefM</italic>. For <italic>yoeB</italic>, primers YoeB_For 5&#x02032;-cgc<bold><italic>ggatcc</italic></bold><underline>gttaactaattaa<italic>caaaggagggtttat</italic></underline>ATGAGCAATTACACGGTTAAG-3&#x02032;, and YoeB_Rev were used to generate a 266 nt product. The underlined lower case nucleotides in YoeB_For incorporate the ribosome binding site that precedes <italic>yefM</italic>, such that both constructs have identical P<sub><italic>cad</italic></sub> promoter and translation initiation signals. PCR products were digested with <italic>BamHI</italic> and <italic>AscI</italic>, and ligated into pCN51 that had been digested with the same enzymes. The ligated plasmids were electroporated into restriction deficient <italic>S. aureus</italic> RN4220, and transformants were selected for growth on BHI agar containing 10 &#x003BC;g/ml erythromycin for maintenance of pCN51.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>CC30 strains are differentiated by conserved pseudogenes</title>
<p>Our present analysis reveals that previously emphasized defects in <italic>hla</italic> and <italic>agrC</italic> (DeLeo et al., <xref ref-type="bibr" rid="B18">2011</xref>), co-associate with lesions in <italic>isdH</italic> and <italic>trpD</italic> (Table <xref ref-type="table" rid="T2">2</xref>). IsdH is a cell surface protein that is highly expressed under iron-limiting conditions, and immunization with IsdH protects against <italic>S. aureus</italic> nasal carriage and bovine mastitis (Clarke et al., <xref ref-type="bibr" rid="B12">2006</xref>; Pilpa et al., <xref ref-type="bibr" rid="B72">2006</xref>; Ster et al., <xref ref-type="bibr" rid="B83">2010</xref>). In EMRSA-16 and ST30<italic>spa33</italic> MSSA, <italic>isdH</italic> has a SNP that converts CAA<sub>Gln</sub> into a TAA stop codon (Table <xref ref-type="table" rid="T2">2</xref>). An observation that many TSST producing strains are auxotrophic for tryptophan (Kreiswirth et al., <xref ref-type="bibr" rid="B44">1989</xref>; Leung et al., <xref ref-type="bibr" rid="B49">1993</xref>) is accounted for by a TG deletion in a 6&#x000D7;TG segment of <italic>trpD</italic>, in the <italic>trpEGDCFBA</italic> locus. Therefore, <italic>agrC</italic>, <italic>hla</italic>, <italic>isdH</italic>, and <italic>trpD</italic> are defective in contemporary MSSA and EMRSA-16 comprising Clade 3, but are functional in PT80/81 and ST30<italic>spa19</italic> CA-MRSA comprising Clades 1 and 2 (Table <xref ref-type="table" rid="T2">2</xref>). These latter strains also have PVL, which together with Type IV <italic>SCCmec</italic> is a trait that Clade 2 CA-MRSA shares with other unrelated CA-MRSA, such as USA300 and USA400. Other CC30 strains A01734/94 (ST30<italic>spa43</italic>), and WW2703/97 (ST30<italic>spa16</italic>) in Clade 3 are defined as CA-MRSA due to Type IV <italic>SCCmec</italic>, but they lack PVL, and have the &#x0201C;pseudogene package&#x0201D; (<italic>agrC</italic>, <italic>hla</italic>, <italic>isdH</italic>, and <italic>trpD</italic>) (Table <xref ref-type="table" rid="T2">2</xref>), which we refer to as a niche-adapted trait.</p>
</sec>
<sec>
<title><italic>S. aureus</italic> pathogenicity island (SaPI) content</title>
<p>Figure <xref ref-type="fig" rid="F1">1</xref> summarizes the distribution of insertion sequence ISSau2, and SaPI&#x00027;s in CC30. Irrespective of gene composition or genetic background, a SaPI is defined by a specific integrase <italic>int</italic> that recognizes an <italic>attS</italic> site (Lindsay and Holden, <xref ref-type="bibr" rid="B52">2004</xref>; Novick and Subedi, <xref ref-type="bibr" rid="B67">2007</xref>). Our analysis reveals that the <italic>attS</italic> sites are always located at the 3&#x02032;-end of a gene, often in association with an operon, and these structures are illustrated in Figure <xref ref-type="fig" rid="F2">2</xref>. As noted previously (DeLeo et al., <xref ref-type="bibr" rid="B18">2011</xref>), SaPI-4 differentiates Clade 3 from Clades 1 and 2. The <italic>attS</italic> of SaPI4 is at the 3&#x02032;-end of the <italic>rpsF-ssb-rpsR</italic> operon, encoding ribosomal protein S6, a single stranded RNA binding protein, and ribosomal protein S18 (Figure <xref ref-type="fig" rid="F2">2A</xref>). SaPI4 does not have any known virulence factors, but SAR0385 encodes a protein with a signal peptide, identical to ORF011 of <italic>S. aureus</italic> phage &#x003D5;1028 (Kwan et al., <xref ref-type="bibr" rid="B47">2005</xref>). Outside of CC30, SaPI4 is restricted to ovine adapted <italic>S. aureus</italic> strains 011 and 046 (Le Marechal et al., <xref ref-type="bibr" rid="B48">2011</xref>), which have an ortholog of SAR0385 (Figure <xref ref-type="fig" rid="F2">2A</xref>). In bovine adapted <italic>S. aureus</italic> ET3-1 (Herron-Olson et al., <xref ref-type="bibr" rid="B36">2007</xref>), an ortholog of SAR0385 is on SaPIbov, where it is flanked by <italic>tst</italic>, <italic>sec</italic>, and <italic>sel</italic> encoding superantigen toxins (Figure <xref ref-type="fig" rid="F2">2A</xref>). The <italic>attS</italic> of SaPIbov spans the 3&#x02032;- end of the <italic>xpt-pbuX-guaB-guaA</italic> operon, encoding genes for transport and metabolism of purine nucleotides. The <italic>rpsR</italic> and <italic>guaA</italic> genes, which contain the <italic>attS</italic> sites for SaPI4 and SaPIbov, respectively, are in close proximity (Figure <xref ref-type="fig" rid="F1">1</xref>), and segments of SaPIbov exhibit high similarity to &#x003D5;1028, and SaPI4 (Figure <xref ref-type="fig" rid="F2">2A</xref>), but there are no genomes that have both SaPI&#x00027;s.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>SaPI structures and insertion sites. (A)</bold> SaPI4, with an illustration of the <italic>rpsF-ssb-rpsR</italic> operon, and nucleotide sequence extending from the 3&#x02032;-end of <italic>rpsR</italic>. The <italic>attS</italic> of SaPI4 shaded gray, overlaps the 3&#x02032;-end of the <italic>rpsR</italic> open reading frame, and letters above the sequence correspond to the C-terminus of RpsR protein. Arrows above the nucleotide sequence indicate inverted repeats, likely comprising a transcriptional terminator. Illustrations below the sequence compare SaPI4 of <italic>S. aureus</italic> MRSA 252 with that of ovine adapted strain 011. The duplicated left and right <italic>attS</italic> sequences are shaded gray, <italic>int</italic> genes are colored orange, while SAR0385 and orthologous genes, encoding a putative secreted protein, are magenta. A central outlined and shaded segment of SaPI4 is highly conserved in <italic>S. aureus</italic> phage &#x003D5;1028, and SaPIbov of bovine adapted <italic>S. aureus</italic> ET3-1. Genes in SaPIbov encoding superantigen toxins are shaded red. The <italic>int</italic> of SaPIbov is shaded orange to emphasize function, although each SaPI family has a distinct <italic>int</italic> and <italic>attS</italic>. Structures of SaPI2 <bold>(B)</bold>, SaPI3 <bold>(C)</bold>, SaPI1 <bold>(D)</bold>, and their genomic insertion sites. Features are labeled as in <bold>A</bold>. SaPI2 of ST30<italic>spa</italic>33 strain MN8 <bold>(B)</bold>, is compared to SaPI2 of a non-related MRSA strain N315. SaPI3 <bold>(C)</bold> is not present in CC30. Structures shown are from strain USA400 [Baba et al. (<xref ref-type="bibr" rid="B4">2002</xref>)], which is a CA-MRSA, and strain 68111, which is a triple locus MLST variant of ST30 [Li et al. (<xref ref-type="bibr" rid="B50">2011</xref>)]. A clonal complex is comprised of isolates that differ from the ancestral sequence type (ST) at no more than two of seven MLST alleles. Therefore, <italic>S. aureus</italic> 68111 is distantly related to ST30, but is not within CC30. <bold>(D)</bold> shows SaPI1 structures from different strains, in comparison to SaPI1 in Clade 1 PT80/81 strains, and Clade 2 ST30<italic>spa</italic>19 CA-MRSA.</p></caption>
<graphic xlink:href="fcimb-02-00048-g0002.tif"/>
</fig>
<p>In CC30, the toxic shock syndrome toxin <italic>tst</italic> is on SaPI2, where <italic>attS</italic> spans the 3&#x02032;-end of <italic>groES-groEL</italic> (Figure <xref ref-type="fig" rid="F2">2B</xref>). In CC30, <italic>tst</italic> is the only toxin on SaPI2, but in unrelated HA-MRSA strains N315 and Mu50 (Kuroda et al., <xref ref-type="bibr" rid="B46">2001</xref>), SaPI2 has additional superantigen toxins <italic>sec</italic> and <italic>sel</italic> (Figure <xref ref-type="fig" rid="F2">2B</xref>). In another non-CC30 strain, <italic>tst</italic> co-associates with <italic>sec</italic> and <italic>sel</italic> in SaPI3 (Li et al., <xref ref-type="bibr" rid="B50">2011</xref>), where <italic>att</italic>S overlaps with the 3&#x02032;-end of <italic>rnr-smpB-ssrA</italic> (Figure <xref ref-type="fig" rid="F2">2C</xref>). This operon encodes a ribonuclease (<italic>rnr</italic>), a non-translated RNA <italic>ssrA</italic>, and its cognate binding protein <italic>smpB</italic>. In the USA400 CA-MRSA, SaPI3 has superantigen toxins <italic>sec</italic> and <italic>sel</italic>, but not <italic>tst</italic>. However, CC30 genomes do not have SaPI3.</p>
<p>The first SaPI identified in <italic>S. aureus</italic> was SaPI1 in strain RN4282 (Lindsay et al., <xref ref-type="bibr" rid="B53">1998</xref>; Ruzin et al., <xref ref-type="bibr" rid="B76">2001</xref>), which has superantigen enterotoxins <italic>sek</italic> and <italic>seq</italic> at the 5&#x02032;-end, and <italic>tst</italic> at the 3&#x02032;-end (Figure <xref ref-type="fig" rid="F2">2D</xref>). The genome of RN4282 was not sequenced, but the flanking <italic>attS</italic> sequences of SaPI1 establish the integration site at the 3&#x02032;-end of <italic>metNPQ</italic>, encoding a putative methionine transporter. Similar SaPI1 structures are in <italic>S. aureus</italic> COL and USA300, although these lack <italic>tst</italic> (Figure <xref ref-type="fig" rid="F2">2D</xref>). In CC30 SaPI1 is present in Clade 1 and 2 strains (Table <xref ref-type="table" rid="T2">2</xref>), but does not have any obvious virulence factors. Similar SaPI1 structures that lack known virulence factors are in <italic>S. aureus</italic> ED98 (Lowder et al., <xref ref-type="bibr" rid="B54">2009</xref>), which has undergone a recent evolutionary transition from human to poultry host, and in bovine adapted strain LGA251 (Garcia-Alvarez et al., <xref ref-type="bibr" rid="B28">2011</xref>). In summary, although <italic>tst</italic> has been identified on SaPI1, SaPI2, SaPI3, and SaPIbov, depending on the genetic background, our data indicate that in CC30 it exclusively resides on SaPI2, where unlike other SaPI2 structures, <italic>tst</italic> does not co-associate with other superantigen toxins.</p>
</sec>
<sec>
<title>Analysis of ISSau2 content</title>
<p>CC30 strains are distinguished by their profiles of ISSau2 (Figure <xref ref-type="fig" rid="F1">1</xref>), which is a member of the IS3 family (<ext-link ext-link-type="uri" xlink:href="http://www-is.biotoul.fr/is.html">www-is.biotoul.fr/is.html</ext-link>). In <italic>E. coli</italic>, IS3 is flanked by imperfect inverted 39 nucleotide repeats with terminal 5&#x02032;-TG and CA-3&#x02032; dinucleotides, and has two overlapping reading frames <italic>orfA</italic> and <italic>orfB</italic>, which when produced by default, prohibit transposition (Timmerman and Tu, <xref ref-type="bibr" rid="B85">1985</xref>; Sekine et al., <xref ref-type="bibr" rid="B80">1997</xref>). A &#x02013;1 translational frame-shift within a poly-A tract in the region of overlap between <italic>orfA</italic> and <italic>orfB</italic> produces a single protein that catalyzes transposition (Prere et al., <xref ref-type="bibr" rid="B73">1990</xref>; Sekine et al., <xref ref-type="bibr" rid="B79">1994</xref>), with duplication of a three base pair target site (Sekine et al., <xref ref-type="bibr" rid="B79">1994</xref>, <xref ref-type="bibr" rid="B80">1997</xref>). ISSau2 has similar features (Figure <xref ref-type="fig" rid="F3">3A</xref>), and targets inverted repeats (Figures <xref ref-type="fig" rid="F3">3B&#x02013;G</xref>), likely comprising <italic>rho</italic>-independent transcription terminators. An ancestral insertion common to CC30 genomes occurs in the intergenic segment separating <italic>trpS</italic> from the <italic>oppAFDBC</italic> oligopeptide permease operon (Figure <xref ref-type="fig" rid="F3">3B</xref>). ST30<italic>spa19</italic> CA-MRSA and PT80/81 have one additional insertion, adjacent to a 16S-23S-5S rRNA operon (Figures <xref ref-type="fig" rid="F3">1</xref> and <xref ref-type="fig" rid="F3">3C</xref>). Two other 16S-23S-5S-rRNA loci are targeted in EMRSA-16, which has a third unique insertion adjacent to <italic>sbcDC</italic> (Figures <xref ref-type="fig" rid="F1">1</xref>, and <xref ref-type="fig" rid="F3">3D,F</xref>). A fourth insertion adjacent to <italic>rplQ</italic> is also present in ST30<italic>spa33</italic> MSSA (Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F3">3E</xref>), including strain MN8, a prototypic menstrual toxic shock strain (Schlievert and Blomster, <xref ref-type="bibr" rid="B78">1983</xref>). MN8 is distinguished from other ST30<italic>spa33</italic> strains by two unique insertions (Figure <xref ref-type="fig" rid="F1">1</xref>), one of which is adjacent to <italic>saeRS</italic> (Figure <xref ref-type="fig" rid="F3">3G</xref>), encoding a two-component sensor signal transduction system that is a major regulator of virulence.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>Illustration of ISSau2 (A) and its insertion sites (B&#x02013;G) in CC30.</bold> ISSau2 is comprised of <italic>orfA</italic> and <italic>orfB</italic> <bold>(A)</bold>, flanked by 39 nt inverted repeats IR-L and IR-R, with terminal 5&#x02032;-TG and 3&#x02032;-CA dinucleotides <bold>(A)</bold>. The sequence above the illustration spans the 3&#x02032;-end of <italic>orfA</italic> and 5&#x02032;-end of <italic>orfB</italic>. The &#x0002B;1 translation of <italic>orfA</italic>, terminating at a stop codon, is shown below the sequence. Above the sequence is a translation that would result from a &#x02212;1 frame-shift within <bold><italic>AAAAAAG</italic></bold>. The &#x02212;1 translation from this point onwards continues throug to the end of <italic>orfB</italic>, and would produce a single 1569 nt trans-frame protein. <bold>(B)</bold> Illustration of <italic>oppAFBDC</italic> and <italic>trpS</italic> genome segment of non-CC30 strain USA300. Beneath this is shown the <italic>oppC-trpS</italic> intergenic sequence of USA300, aligned to that MRSA 252. Asterisks above the USA300 sequence indicate stop codons of <italic>oppC</italic> and <italic>trpS</italic>. Convergent arrows indicate inverted repeats, likely comprising a <italic>rho</italic>-independent transcription terminator stem-loop structure. In all CC30 strains, the left arm of the stem is disrupted by a flanking repeat of IS1272 (shaded gray), which in turn is disrupted by ISSau2. In MRSA 252, <italic>oppB</italic> (cross-hatched) has an in-frame internal deletion that is unique to the EMRSA-16 lineage. <bold>(C)</bold> ISSau2 insertion in the genome of <italic>S. aureus</italic> TCH60 (top), which is ST30<italic>spa19</italic> CA-MRSA (Clade 2), and corresponding segment of MRSA 252 (bottom). PCR with primers spanning the 3&#x02032;-end of the 5S rRNA and flanking <italic>ilvA</italic> (right panel) reveal that this insertion is in Clade 1 strains (M809, M1015) and another Clade 2 CA-MRSA (WBG10049), but not other CC30, including strains that pre-date the Clade 1 pandemic (ATCC12598, NRS204, ATCC25923). <bold>(D)</bold> ISSau2 insertion adjacent to a 16S-23S-5S rRNA operon, and flanking <italic>okrD</italic> gene, which is unique to Clade 3 HA-MRSA. The sequence below the illustration shows the end of the 5S rRNA transcript, and adjacent <italic>rho</italic>-independent transcriptional terminator, comprised of tandem stem-loops followed by a poly-T segment. ISSau2 disrupts the right arm of the first stem-loop, with duplication of the CAT target site. <bold>(E and F)</bold> show similar disruption of a putative stem-loop structure downstream of <italic>rplQ</italic>, and a likely transcription terminator of the <italic>sbcDC</italic> operon. <bold>(G)</bold> Unique ISSau2 insertion in ST30<italic>spa</italic>33 strain MN8 disrupts stem-loop structure adjacent to <italic>saeRS</italic> regulator. The <italic>saeRS</italic> genome segment of MRSA 252 is shown for reference, and the nucleotide sequence downstream of <italic>saeS</italic> is shown above the illustration. In strain MN8, ISSau2 inserts into the left arm of a putative stem-loop structure, with duplication of the CTC target site. This is confirmed by PCR of a genomic segment spanning <italic>saeS</italic> and adjacent SAR0757, producing a 2.8 kb amplicon in MN8 (Lane 6), and a 1.2 kb product in all other strains including PT80/81 strain M1015 (Lane 1), ST30<italic>spa19</italic> CA-MRSA strain WBG10049 (Lane 2), ST36<italic>spa16</italic> HA-MRSA strains PM7 and PM64 (Lanes 3 and 4), and additional ST30<italic>spa</italic>33 strains UAMS-1 (Lane 5), L516 (Lane 7), and L528 (Lane 8).</p></caption>
<graphic xlink:href="fcimb-02-00048-g0003.tif"/>
</fig>
<p>Outside of CC30, ISSau2 is restricted to animal adapted <italic>S. aureus</italic>. Ovine adapted ED133 has seven copies (Guinane et al., <xref ref-type="bibr" rid="B32">2010</xref>), bovine strain LGA251 has three (Garcia-Alvarez et al., <xref ref-type="bibr" rid="B28">2011</xref>), and porcine adapted ST398 has one (Schijffelen et al., <xref ref-type="bibr" rid="B77">2010</xref>). The unassembled genomes of ovine strains 011 and 046 also have at least one copy (Le Marechal et al., <xref ref-type="bibr" rid="B48">2011</xref>). In these animal adapted strains, the integration sites for ISSau2 are mutually exclusive of those in CC30.</p>
</sec>
<sec>
<title>Loss of a toxin&#x02013;antitoxin addiction module in CC30 evolution</title>
<p>Toxin-antitoxin (TA) modules encode a stable bactericidal or bacteriostatic toxin, and an unstable antitoxin that forms an inhibitory complex with the toxin. These were first termed addiction modules when discovered on plasmids, since loss of the plasmid during cell division leads to rapid degradation of the unstable antitoxin, followed by activation of the toxin and death of the daughter cells (Meinhart et al., <xref ref-type="bibr" rid="B59">2003</xref>). Most free-living bacteria also have one or more genomic TA modules (Pandey and Gerdes, <xref ref-type="bibr" rid="B70">2005</xref>). An example in <italic>S. aureus</italic> is <italic>mazEF</italic>, where MazF is an RNA&#x00027;se that induces cell stasis by degradation of mRNA (Fu et al., <xref ref-type="bibr" rid="B27">2007</xref>), and MazE is the antitoxin. Most other <italic>S. aureus</italic> genomes have another uncharacterized TA module, similar to <italic>yefM-yoeB</italic> in <italic>E. coli</italic>, where YoeB is a stasis-inducing RNA&#x00027;se and YefM is the antitoxin (Kamada and Hanaoka, <xref ref-type="bibr" rid="B41">2005</xref>). In ST30<italic>spa19</italic> CA-MRSA and PT80/81, <italic>yefM-yoeB</italic> is flanked by <italic>frvX</italic> encoding an M42 metallopeptidase/endoglucanase protein family member, and a predicted glutamate synthase, <italic>gltS</italic> (Figure <xref ref-type="fig" rid="F4">4A</xref>). In MRSA 252, the flanking genes <italic>frvX</italic> (SAR2545) and <italic>gltS</italic> (SAR2547) are present, but not <italic>yefM-yoeB</italic>, and this is also characteristic of contemporary CC30 MSSA. Other genomes with this trait are restricted to ST398 porcine adapted <italic>S. aureus</italic>, ovine adapted strains 011 and 046, and as yet undefined strains A9635 and 21200.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>(A)</bold> Illustration of <italic>yefM-yoeB</italic> and flanking DNA in CC30. <italic>yefM-yoeB</italic> are flanked by repeats LDR-1 and LDR-2 (black bars) in PT80/81 and ST30<italic>spa19</italic> CA-MRSA, whereas HA-MRSA and contemporary MSSA have only one LDR and lack <italic>yefM-yoeB</italic>. <bold>(B)</bold> Nucleotide sequence of LDR-1 and LDR-2 from strain M1015, and the single LDR of MRSA 252. The lower-case gray shaded nucleotides differentiate LDR-1 and LDR-2. The single LDR of MRSA 252 is a hybrid of LDR-1 and LDR-2, which is suggestive of a recombination event. <bold>(C)</bold> Growth of <italic>S. aureus</italic> RN4220 harboring P<sub><italic>cad</italic></sub>::<italic>yefM-yoeB</italic> or P<sub><italic>cad</italic></sub>::<italic>yoeB</italic>, on BHI agar, or BHI supplemented with 5 &#x003BC;M cadmium, to induce P<sub><italic>cad</italic></sub>.</p></caption>
<graphic xlink:href="fcimb-02-00048-g0004.tif"/>
</fig>
<p>Although not annotated, <italic>yefM-yoeB</italic> is flanked by long direct repeats LDR-1 and LDR-2 (Figure <xref ref-type="fig" rid="F4">4B</xref>). CC30 genomes that lack <italic>yefM-yoeB</italic> have a single repeat identical to LDR-1, except for two SNP&#x00027;s at the 3&#x02032;-end that match LDR-2, suggesting that deletion occurred by recombination between LDR-1 and LDR-2. To assess the function of <italic>yoeB</italic>, it was cloned by itself, or paired with <italic>yefM</italic>, in plasmid pCN51 under transcriptional control of P<sub><italic>cad</italic></sub>. Cells of <italic>S. aureus</italic> RN4220 with either plasmid grew well on BHI agar, but on induction with cadmium, cells with <italic>yoeB</italic> alone did not grow (Figure <xref ref-type="fig" rid="F4">4C</xref>), confirming its function as a toxin, likely through degradation of mRNA to induce cellular stasis.</p>
</sec>
<sec>
<title>Production of secreted proteins</title>
<p>Clade 3 MSSA (ST30<italic>spa</italic>33) are recovered from a spectrum of conditions, including osteomyelitis (Cassat et al., <xref ref-type="bibr" rid="B8">2005</xref>), infective endocarditis (Nienaber et al., <xref ref-type="bibr" rid="B65">2011</xref>), bacteremia (Xiong et al., <xref ref-type="bibr" rid="B91">2009</xref>), and menstrual toxic shock (Lin et al., <xref ref-type="bibr" rid="B51">2011</xref>). Although these all have the same premature stop codon in <italic>hla</italic>, strains associated with menstrual toxic shock were reported to retain the ability to produce a small amount of Hla (Lin et al., <xref ref-type="bibr" rid="B51">2011</xref>). Further, our data establish that MN8, which is a prototypic menstrual toxic shock strain (Altemeier et al., <xref ref-type="bibr" rid="B2">1981</xref>), is differentiated from other Clade 3 MSSA by unique ISSau2 insertions (Figures <xref ref-type="fig" rid="F1">1</xref>,<xref ref-type="fig" rid="F3">3</xref> and Table <xref ref-type="table" rid="T2">2</xref>), suggesting that it could also have unique phenotypic traits. We, therefore, evaluated production of secreted proteins in the major CC30 clonal types, including PT80/81 (Clade 1), ST30<italic>spa19</italic> CA-MRSA (Clade 2), HA-MRSA (Clade 3), and Clade 3 MSSA recovered from menstrual toxic shock (MN8), osteomyelitis (UAMS-1), infective endocarditis (L516), and bacteremia (L528). Compared to other Clade 3 MSSA, MN8 exhibited more abundant production of secreted proteins (Figure <xref ref-type="fig" rid="F5">5A</xref>), and when compared to UAMS-1 on three separate occasions, it always produced more secreted protein (data not shown). However, irrespective of this difference, Hla was not detected in any of the ST30<italic>spa</italic>33 MSSA in a Western blot (Figure <xref ref-type="fig" rid="F5">5B</xref>).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><bold>Assessment of CC30 secreted proteins by SDS-PAGE (A) and Western blot for detection of Hla (B).</bold> The individual strains are the same as defined in Figure <xref ref-type="fig" rid="F3">3G</xref>. For visualization of secreted proteins by Coomassie Blue staining <bold>(A)</bold>, a total of 3.0 OD<sub>600</sub> units of cell-free culture supernatant was applied to each lane, while 0.02 OD units was applied in Figure <xref ref-type="fig" rid="F3">3B</xref>. Zones I, II, and III as outlined in the SDS-PAGE gel <bold>(A)</bold> are enlarged in Figure <xref ref-type="fig" rid="F3">3C</xref>. The numbered protein bands were excised from the gel, followed by trypsin digestion and mass spectrometry. The identity of proteins in each band is provided in Table <xref ref-type="table" rid="T3">3</xref>.</p></caption>
<graphic xlink:href="fcimb-02-00048-g0005.tif"/>
</fig>
<p>Proteins from zones I, II, and III on the SDS-PAGE (Figure <xref ref-type="fig" rid="F5">5A</xref>) were selected for trypsin digestion and mass spectrometry (Figure <xref ref-type="fig" rid="F5">5C</xref> and Table <xref ref-type="table" rid="T3">3</xref>). HA-MRSA and ST30<italic>spa</italic>33 MSSA secreted toxic shock syndrome toxin TSST (Zone II, band 7), encoded by <italic>tst</italic> on SaPI2, and except for UAMS-1, they also secreted the SAR0385 gene product encoded on SaPI4 (Zone III, band 8). PT80/81 and CA-MRSA produced Hla (Zone I, band 3 and some carry-over in band 4), but Hla was not identified in the co-migrating protein bands from strain MN8. The PT80/81 strain was unique in abundant production of the LukF component of PVL (Zone I, band 2). All strains produced mature glycerol ester hydrolase/lipase (Zone I, band 1), &#x003B3;-hemolysin components HglC and HglB (band 2 and carry-over in 3), and glycerolphosphoryl diester phosphodiesterase (band 4). With the exception of CA-MRSA, band 4 also contained the HglA component of &#x003B3;-hemolysin. Therefore, although our data support the contention that Clade 3 MSSA associated with Staphylococcal toxic shock syndrome may be more virulent due to elevated production of secreted proteins, including &#x003B3;-hemolysin, we found no evidence to support their production of Hla.</p>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p><bold>Identity of proteins excised from SDS-PAGE (Figures. <xref ref-type="fig" rid="F5">5A</xref> and C)</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left"><bold>Zone</bold></th>
<th align="left"><bold>Band</bold></th>
<th align="left"><bold>Strain</bold></th>
<th align="left"><bold>Protein</bold></th>
<th align="left"><bold>Accession</bold></th>
<th align="left"><bold>C.I.</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">I</td>
<td align="left">1</td>
<td align="left">PT80/81 HA-MRSA MN8</td>
<td align="left">lipase precursor</td>
<td align="left">gi|49482552</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">HA-MRSA</td>
<td align="left">lipase precursor</td>
<td align="left">gi|49482552</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">MN8</td>
<td align="left">lipase precursor</td>
<td align="left">gi|49482552</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td align="left">2</td>
<td align="left">PT80/81</td>
<td align="left">gamma hemolysin HglC component</td>
<td align="left">gi|4948637</td>
<td align="left">99.99</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">gamma hemolysin HglB component</td>
<td align="left">gi|477912</td>
<td align="left">99.19</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">LukF-PV</td>
<td align="left">gi|9635192</td>
<td align="left">97.83</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">CA-MRSA</td>
<td align="left">gamma hemolysin HglC component</td>
<td align="left">gi|4948637</td>
<td align="left">99.99</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">gamma hemolysin HglB component</td>
<td align="left">gi|477912</td>
<td align="left">99.94</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">HA-MRSA</td>
<td align="left">gamma hemolysin HglC component</td>
<td align="left">gi|4948637</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">autolysin protein</td>
<td align="left">gi|32968086</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">gamma hemolysin HglB component</td>
<td align="left">gi|477912</td>
<td align="left">99.96</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">MN8</td>
<td align="left">gamma hemolysin HglC component</td>
<td align="left">gi|4948637</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">gamma hemolysin HglB component</td>
<td align="left">gi|477912</td>
<td align="left">99.98</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">autolysin protein</td>
<td align="left">gi|32968086</td>
<td align="left">83.16</td>
</tr>
<tr>
<td/>
<td align="left">3</td>
<td align="left">PT80/81</td>
<td align="left">alpha hemolysin precursor</td>
<td align="left">gi|15924153</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">CA-MRSA</td>
<td align="left">alpha hemolysin precursor</td>
<td align="left">gi|15924153</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">MN8</td>
<td align="left">gamma hemolysin HglC component</td>
<td align="left">gi|49484636</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">lipase precursor</td>
<td align="left">gi|49482552</td>
<td align="left">76.21</td>
</tr>
<tr>
<td/>
<td align="left">4</td>
<td align="left">PT80/81</td>
<td align="left">glycerolphosphoryl diester phosphodiesterase</td>
<td align="left">gi|49483119</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">gamma hemolysin HglA component</td>
<td align="left">gi|49484635</td>
<td align="left">99.88</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">CA-MRSA</td>
<td align="left">glycerolphosphoryl diester phosphodiesterase</td>
<td align="left">gi|49483119</td>
<td align="left">99.99</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">alpha hemolysin precursor</td>
<td align="left">gi|15924153</td>
<td align="left">99.99</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">nucleotidase lipoprotein</td>
<td align="left">gi|49482539</td>
<td align="left">65.61</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">MN8</td>
<td align="left">gamma hemolysin HglA component</td>
<td align="left">gi|49484635</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">glycerolphosphoryl diester phosphodiesterase</td>
<td align="left">gi|49483119</td>
<td align="left">86.31</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">L516</td>
<td align="left">glycerolphosphoryl diester phosphodiesterase</td>
<td align="left">gi|49483119</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">gamma hemolysin HglA component</td>
<td align="left">gi|49484635</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">L528</td>
<td align="left">glycerolphosphoryl diester phosphodiesterase</td>
<td align="left">gi|49483119</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">gamma hemolysin chain II (HglA) component</td>
<td align="left">gi|15925409</td>
<td align="left">97.77</td>
</tr>
<tr>
<td/>
<td align="left">5</td>
<td align="left">PT80/81</td>
<td align="left">lipase precursor</td>
<td align="left">gi|49482552</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">MN8</td>
<td align="left">lipase precursor</td>
<td align="left">gi|49482552</td>
<td align="left">100</td>
</tr>
<tr>
<td align="left">II</td>
<td align="left">6</td>
<td align="left">PT80/81</td>
<td align="left">Staphopain cysteine protease</td>
<td align="left">gi|3891901</td>
<td align="left">96.7</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td align="left">alkyl hydroperoxidase subunit C</td>
<td align="left">gi|15923371</td>
<td align="left">29.78</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">CA-MRSA</td>
<td align="left">alkyl hydroperoxidase subunit C</td>
<td align="left">gi|15923371</td>
<td align="left">91.75</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">HA-MRSA</td>
<td align="left">alkyl hydroperoxidase subunit C</td>
<td align="left">gi|15923371</td>
<td align="left">99.8</td>
</tr>
<tr>
<td/>
<td align="left">7</td>
<td align="left">HA-MRSA</td>
<td align="left">toxic shock syndrome toxin-1</td>
<td align="left">gi|18535666</td>
<td align="left">99.95</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">HA-MRSA</td>
<td align="left">toxic shock syndrome toxin-1</td>
<td align="left">gi|18535666</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">UAMS-1</td>
<td align="left">toxic shock syndrome toxin-1</td>
<td align="left">gi|18535666</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">MN8 L516</td>
<td align="left">toxic shock syndrome toxin-1</td>
<td align="left">gi|18535666</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">L516</td>
<td align="left">toxic shock syndrome toxin-1</td>
<td align="left">gi|18535666</td>
<td align="left">100</td>
</tr>
<tr>
<td align="left">III</td>
<td align="left">8</td>
<td align="left">PT80/81</td>
<td align="left">hypothetical protein SAR0622</td>
<td align="left">gi|49482843</td>
<td align="left">99.93</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">CA-MRSA</td>
<td align="left">hypothetical protein SAR0622</td>
<td align="left">gi|49482843</td>
<td align="left">99.89</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">HA-MRSA</td>
<td align="left">hypothetical protein SAR0385</td>
<td align="left">gi|49482618</td>
<td align="left">98.66</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">UAMS-1</td>
<td align="left">hypothetical protein SAR0622</td>
<td align="left">gi|49482843</td>
<td align="left">100</td>
</tr>
<tr>
<td/>
<td/>
<td align="left">MN8</td>
<td align="left">hypothetical protein SAR0385</td>
<td align="left">gi|49482618</td>
<td align="left">98.66</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Gene gain, gene loss, and gene change are major forces in bacterial genome dynamics (Moran and Plague, <xref ref-type="bibr" rid="B63">2004</xref>; Pallen and Wren, <xref ref-type="bibr" rid="B69">2007</xref>), and we have evaluated these processes in <italic>S. aureus</italic> clonal complex CC30. It was previously established that MRSA 252, representing the EMRSA-16 lineage, has the highest content of pseudogenes compared to other <italic>S. aureus</italic> genomes (Holden et al., <xref ref-type="bibr" rid="B37">2004</xref>; Lindsay and Holden, <xref ref-type="bibr" rid="B52">2004</xref>). A bovine adapted strain ET3-1 was a close second, and several of the accumulated pseudogenes would eliminate production of a number of cell surface proteins and iron acquisition pathways (Herron-Olson et al., <xref ref-type="bibr" rid="B36">2007</xref>). Importantly, the most robust examples of gene decay come from recently emerged pathogens that have changed lifestyle, usually to live in a simpler host-associated niche (Moran and Plague, <xref ref-type="bibr" rid="B63">2004</xref>). As summarized in Table <xref ref-type="table" rid="T2">2</xref>, defining traits of CC30 Clade 3 include (1), a premature stop codon in <italic>hla</italic> encoding &#x003B1;-Hemolysin; (2), a SNP that causes an Gly<sub>55</sub>&#x0003E;Arg substitution in the AgrC membrane sensor protein, leading to attenuated transcription of the regulatory RNAIII that is needed to produce secreted virulence factors; (3), <italic>isdH</italic> and <italic>trpD</italic> pseudogenes; (4), acquisition of SaPI4, and in most isolates also SaPI2, which possesses the <italic>tst</italic> gene encoding toxic shock syndrome toxin, and (5), an increase in copy number of ISSau2 relative to Clades 1 and 2. Our analyses have revealed several features that were not previously identified through comparative genome sequencing (DeLeo et al., <xref ref-type="bibr" rid="B18">2011</xref>). These include the presence of SaPII and a functional TA genomic addiction module in Clades 1 and 2, the identification of SaPI2 in Clade 3, and the occurrence of unique ISSau2 insertions in each of the three major Clades. Cumulatively, these findings are concordant with niche adaptation in CC30 Clade 3.</p>
<p>It has long been known that 80% of TSST producing <italic>S. aureus</italic> strains are auxotrophic for tryptophan (Chu et al., <xref ref-type="bibr" rid="B11">1985</xref>; Leung et al., <xref ref-type="bibr" rid="B49">1993</xref>), which we now attribute to a TG deletion in <italic>trpD</italic>. It is believed that amino acid auxotrophy contributes to niche adaptation, because auxotrophic bacteria are restricted to a niche where the appropriate amino acid can be obtained. <italic>Lactococcus lactis</italic> recovered from dairy products are auxotrophic for histidine due to frame-shift mutations in <italic>hisC</italic>, <italic>hisG</italic>, and <italic>hisH</italic>, while strains from non-dairy sources are prototrophic (Delorme et al., <xref ref-type="bibr" rid="B19">1993</xref>). <italic>S. aureus</italic> ET3-1, which is a predominant clonal type associated with bovine mastitis, also has a frame-shift mutation in <italic>hisC</italic> (SAB2553), which does not occur in other <italic>S. aureus</italic> genomes. The <italic>trpD</italic> gene, which has a TG insertion in CC30 Clade 3, is part of the <italic>trpEGDCFBA</italic> transcriptional unit, of which <italic>trpBA</italic> encode the subunits of tryptophan synthase, and <italic>trpEGDCF</italic>, encode enzymes necessary for synthesis of indole precursor. <italic>Chlamydia trachomatis</italic> uniformly lack the genes needed to produce indole, but strains that cause ocular vs. genital infections can be differentiated on the basis of the latter being able to produce a functional tryptophan synthase, and it is postulated that tryptophan can be produced by condensation of serine with exogenous indole produced by microflora in the female genital tract (Fehlner-Gardiner et al., <xref ref-type="bibr" rid="B23">2002</xref>; McClarty et al., <xref ref-type="bibr" rid="B57">2007</xref>). Consequently, tryptophan auxotrophy may contribute to tropism of TSST producing CC30 strains for the vaginal mucosa.</p>
<p>Another important factor in evolution of niche adapted strains is an increase in copy number of IS elements, leading to genome deletions and inversions through recombination between adjacent IS elements. An interesting example relevant to our analysis is a reduction in the numbers of operons encoding 16S-23S rRNA in microbial endosymbionts of insect cells (Andersson and Andersson, <xref ref-type="bibr" rid="B3">1999</xref>; Itoh et al., <xref ref-type="bibr" rid="B39">2002</xref>). This was attributed to IS integration within operons encoding 16S-23S rRNA, followed by recombination to generate deletions (Dale et al., <xref ref-type="bibr" rid="B15">2003</xref>). It is, therefore, striking that all three 16S-23S-5S rRNA loci in the CC30 genome are targeted by ISSau2, with an insertion at rRNA-3 being unique to Clade 1, while insertions at rRNA-1 and rRNA-2 are unique to HA-MRSA in Clade 3 (Figure <xref ref-type="fig" rid="F1">1</xref> and Table <xref ref-type="table" rid="T2">2</xref>). Our analysis suggests that the insertions adjacent to rRNA operons is due to the propensity of ISSau2 to target inverted repeats, which likely comprise <italic>rho</italic>-independent transcription terminators. ISSau2 is a member of the IS30 family, and two unusual members of the IS30 family in <italic>Mycoplasma fermentans</italic> and <italic>M. bovis</italic>, which are obligate intracellular parasites, also target <italic>rho</italic>-independent transcription terminators, which remain intact and are partially duplicated on transposition (Calcutt et al., <xref ref-type="bibr" rid="B7">1999</xref>; Lysnyansky et al., <xref ref-type="bibr" rid="B55">2009</xref>). Conversely, our data suggest that ISSau2 either disrupts or weakens stem loop structures, as illustrated in Figures <xref ref-type="fig" rid="F3">3D&#x02013;G</xref>.</p>
<p>Depending on the orientation of ISSau2 with respect to the adjacent gene, this could have important consequences with respect to control of transposition. It is widely accepted that transposition must be maintained at a low level, a commonly cited reason being that excessive transposition is detrimental to the stability of the host genome (Doolittle et al., <xref ref-type="bibr" rid="B20">1984</xref>). Therefore, endogenous transposase promoters are generally weak, and often partially located in the inverted flanking repeats, such that strong promoters can only be created by juxtaposition of inverted repeats due to formation of head-to tail dimers, or circular copies of the IS as noted for the IS30 family (Dalrymple, <xref ref-type="bibr" rid="B16">1987</xref>). IS elements also have mechanisms to attenuate their activation by impinging transcription, following insertion into active host genes. Impinging transcription across the inverted flanking repeats can either sequester translation initiation signals, or disrupt complex formation between the transposase and inverted repeats. These considerations may help to explain the insertion of ISSau2 adjacent to highly transcribed genes, including all three rRNA operons in the CC30 genome, and adjacent to <italic>rplQ</italic> encoding the 50S ribosomal subunit protein L17 (Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F3">3</xref>). In these situations, ISSau2 is oriented in the antisense orientation with respect to the adjacent gene, such that impinging transcription would also generate antisense RNA to the transposase genes.</p>
<p>In an example that is unique to HA-MRSA in Clade 3 (Figure <xref ref-type="fig" rid="F1">1</xref> and Table <xref ref-type="table" rid="T2">2</xref>), ISSau2 is inserted in the sense orientation adjacent to <italic>sbcDC</italic> (Figure <xref ref-type="fig" rid="F3">3F</xref>), disrupting the predicted transcriptional terminator. The <italic>sbcDC</italic> genes encode a protein complex that recognizes and cleaves hairpin structures in DNA, has a major role in promoting genome stability and repair of breaks in double stranded DNA, and is induced by the SOS stress response in <italic>S. aureus</italic> (Connelly et al., <xref ref-type="bibr" rid="B13">1998</xref>; Mascarenhas et al., <xref ref-type="bibr" rid="B56">2006</xref>; Chen et al., <xref ref-type="bibr" rid="B10">2007</xref>; Eykelenboom et al., <xref ref-type="bibr" rid="B22">2008</xref>; Darmon et al., <xref ref-type="bibr" rid="B17">2010</xref>). It is noteworthy in this respect that loss of DNA recombinational repair occurs in the initial stages of genome degeneration, as bacteria undergo a transition from an autonomous free-living state to permanent intracellular existence (Dale et al., <xref ref-type="bibr" rid="B15">2003</xref>). This leads to active expansion of IS elements, which in turn promotes deletion or inversion of genome segments <italic>via</italic> IS-mediated recombination. Therefore, based on established evolutionary trends, the ISSau2 insertion adjacent to <italic>sbcDC</italic> may represent an early stage in the pathway toward genome destabilization.</p>
<p>Whether ISSau2 influences expression of adjacent genes is unknown. However, an insertion that is unique to strain MN8, from a case of menstrual Staphylococcal toxic shock, is adjacent to the <italic>saeRS</italic> two-component sensory signal transducer. SaeRS is a major regulator of virulence in <italic>S. aureus</italic> (Geiger et al., <xref ref-type="bibr" rid="B29">2008</xref>; Voyich et al., <xref ref-type="bibr" rid="B87">2009</xref>; Nygaard et al., <xref ref-type="bibr" rid="B68">2010</xref>), and although there is as yet no evidence that ISSau2 influences expression of <italic>saeRS</italic>, we find that relative to ST30<italic>spa33</italic> strains that lack this insertion, MN8 exhibits more abundant production of secreted proteins, including the HglA, HglB, and HglC components of &#x003B3;-hemolysin, as well as TSST and SAR0385 gene product encoded on SaPI2 and SaPI4, respectively. This is consistent with a recent finding that, with the exception of strain MN8, other ST30<italic>spa33</italic> strains and EMRSA-16 exhibited strongly attenuated transcription of the RNAIII effector component of the <italic>agr</italic> global regulator, due to a common SNP in <italic>agrC</italic> (DeLeo et al., <xref ref-type="bibr" rid="B18">2011</xref>). Although this SNP is also present in strain MN8, transcription of RNAIII was not influenced to the same extent as other strains, suggesting that there was a compensatory mechanism in this strain. Additional work is warranted to determine if this is related to the ISSau2 insertion adjacent to <italic>saeRS</italic>.</p>
<p>The absence of the <italic>yefM-yoeB</italic> TA module (<italic>toxM</italic>) in Clade 3 is also consistent with established evolutionary pathways toward niche adaptation. Most free-living bacteria have multiple genomic TA loci, which are thought to help cope with nutritional stress by inducing a reversible state of dormancy during periods of nutrient depletion (Pedersen et al., <xref ref-type="bibr" rid="B71">2002</xref>; Gerdes et al., <xref ref-type="bibr" rid="B30">2005</xref>), although this has been disputed in <italic>E. coli</italic> (Tsilibaris et al., <xref ref-type="bibr" rid="B86">2007</xref>). However, obligate intracellular pathogens and symbionts experience a less variable environment, and do not have TA modules (Pandey and Gerdes, <xref ref-type="bibr" rid="B70">2005</xref>). Only a few free-living bacteria lack TA modules, the most notable being <italic>Lactococcus lactis</italic>, which is niche-adapted in its association with dairy products. Intriguingly, outside of CC30, the only other <italic>S. aureus</italic> genomes that lack this TA module thus far are restricted to ST398 porcine adapted <italic>S. aureus</italic>, ovine adapted strains 011 and 046, and as yet undefined strains A9635 and 21200. Although we cannot exclude the possibility that this TA module represents a gene acquisition in Clades 1 and 2, rather than a gene deletion in Clade 3, the broad distribution of this element in other <italic>S. aureus</italic> genomes supports the contention that this element is a component of the core genome that is lost in evolutionary development of some strains. However, more work is needed to confirm this hypothesis.</p>
<p>In conclusion, our findings support the notion that Clade 3 is following an evolutionary blueprint toward niche-adaptation, while Clade 2 strains consisting of ST30<italic>spa19</italic> CA-MRSA retain the feral nature of the historic PT80/81 Clade 1. It is important to note that CA-MRSA are defined by Type IV SCC<italic>mec</italic>, which in CC30 is also associated with ST30<italic>spa</italic>43 and ST30<italic>spa</italic>16 strains in Clade 3 (Table <xref ref-type="table" rid="T2">2</xref>). Therefore, strains of CA-MRSA, which are typically associated with hyper-virulence, are emerging with the niche-adapted trait. Given that CA-MRSA must evolve from MSSA through acquisition of Type IV SCC<italic>mec</italic>, this suggests that the niche-adapted trait is widely disseminated in the human population, and this is supported by several key observations. First, MSSA that resemble the EMRSA-16 clone of HA-MRSA (Clade 3) were the most common clonal type associated with asymptomatic nasal carriage in the United States (Kuehnert et al., <xref ref-type="bibr" rid="B45">2006</xref>), and several other studies concur that CC30 is a major clonal complex associated with nasal carriage (Feil et al., <xref ref-type="bibr" rid="B24">2003</xref>; Melles et al., <xref ref-type="bibr" rid="B60">2004</xref>, <xref ref-type="bibr" rid="B61">2008</xref>; Kuehnert et al., <xref ref-type="bibr" rid="B45">2006</xref>; Fowler et al., <xref ref-type="bibr" rid="B26">2007</xref>; Ko et al., <xref ref-type="bibr" rid="B43">2008</xref>). Second, <italic>S. aureus</italic> infections are usually caused by the same strain that is associated with nasal carriage, and in our analysis of a panel of 172 CC30 clinical isolates, the occurrence of the <italic>hla</italic> pseudogene, the <italic>agrC</italic> SNP, and <italic>tst</italic> encoded by SaPI2, which are key markers of Clade 3 (Table <xref ref-type="table" rid="T2">2</xref>), was 70.9%, 72.1%, and 75.6%, respectively, (DeLeo et al., <xref ref-type="bibr" rid="B18">2011</xref>). Third, in a study that assessed nasal carriage isolates from 107 healthy blood donors, 27% were CC30, and 62% of these CC30 strains possessed <italic>tst</italic> (Holtfreter et al., <xref ref-type="bibr" rid="B38">2007</xref>), which is a marker of Clade 3. Moreover, in the same study, <italic>tst</italic> was present in 90% of CC30 bacteremia isolates. In this context, although our studies indicate that the niche adapted trait is associated with attenuated virulence in murine infection models (Holtfreter et al., <xref ref-type="bibr" rid="B38">2007</xref>), a benefit to Clade 3 in having premature stop codons in Hla and IsdH (Table <xref ref-type="table" rid="T2">2</xref>) is that both proteins are considered as potential vaccine antigens (Clarke et al., <xref ref-type="bibr" rid="B12">2006</xref>; Wardenburg and Schneewind, <xref ref-type="bibr" rid="B88">2008</xref>; Kennedy et al., <xref ref-type="bibr" rid="B42">2010</xref>; Ster et al., <xref ref-type="bibr" rid="B83">2010</xref>), and Clade 3 strains would be immune to this vaccine strategy.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
</sec>
</body>
<back>
<ack>
<p>This research was supported by a grant to Martin J. McGavin from the Natural Sciences and Engineering Research Council of Canada.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abbott</surname> <given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Medics braced for fresh superbug</article-title>. <source>Nature</source> <volume>436</volume>, <fpage>758</fpage>. <pub-id pub-id-type="doi">10.1038/436758a</pub-id><pub-id pub-id-type="pmid">16094326</pub-id></citation>
</ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altemeier</surname> <given-names>W. A.</given-names></name> <name><surname>Lewis</surname> <given-names>S.</given-names></name> <name><surname>Schlievert</surname> <given-names>P. M.</given-names></name> <name><surname>Bjornson</surname> <given-names>H. S.</given-names></name></person-group> (<year>1981</year>). <article-title>Studies of the Staphylococcal causation of toxic shock syndrome</article-title>. <source>Surg. Gynecol. Obstet</source>. <volume>153</volume>, <fpage>481</fpage>&#x02013;<lpage>485</lpage>. <pub-id pub-id-type="pmid">6456561</pub-id></citation>
</ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname> <given-names>J. O.</given-names></name> <name><surname>Andersson</surname> <given-names>S. G.</given-names></name></person-group> (<year>1999</year>). <article-title>Insights into the evolutionary process of genome degradation</article-title>. <source>Curr. Opin. Genet. Dev</source>. <volume>9</volume>, <fpage>664</fpage>&#x02013;<lpage>671</lpage>. <pub-id pub-id-type="doi">10.1016/S0959-437X(99)00024-6</pub-id><pub-id pub-id-type="pmid">10607609</pub-id></citation>
</ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname> <given-names>T.</given-names></name> <name><surname>Takeuchi</surname> <given-names>F.</given-names></name> <name><surname>Kuroda</surname> <given-names>M.</given-names></name> <name><surname>Yuzawa</surname> <given-names>H.</given-names></name> <name><surname>Aoki</surname> <given-names>K.</given-names></name> <name><surname>Oguchi</surname> <given-names>A.</given-names></name> <name><surname>Nagai</surname> <given-names>Y.</given-names></name> <name><surname>Iwama</surname> <given-names>N.</given-names></name> <name><surname>Asano</surname> <given-names>K.</given-names></name> <name><surname>Naimi</surname> <given-names>T.</given-names></name> <name><surname>Kuroda</surname> <given-names>H.</given-names></name> <name><surname>Cui</surname> <given-names>L.</given-names></name> <name><surname>Yamamoto</surname> <given-names>K.</given-names></name> <name><surname>Hiramatsu</surname> <given-names>K.</given-names></name></person-group> (<year>2002</year>). <article-title>Genome and virulence determinants of high virulence community-acquired MRSA</article-title>. <source>Lancet</source> <volume>359</volume>, <fpage>1819</fpage>&#x02013;<lpage>1827</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(02)08713-5</pub-id><pub-id pub-id-type="pmid">12044378</pub-id></citation>
</ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brazier</surname> <given-names>J. S.</given-names></name></person-group> (<year>2008</year>). <article-title><italic>Clostridium difficile</italic>: from obscurity to superbug.</article-title> <source>Br. J. Biomed. Sci</source>. <volume>65</volume>, <fpage>39</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="pmid">18476496</pub-id></citation>
</ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bubeck Wardenburg</surname> <given-names>J.</given-names></name> <name><surname>Bae</surname> <given-names>T.</given-names></name> <name><surname>Otto</surname> <given-names>M.</given-names></name> <name><surname>Deleo</surname> <given-names>F. R.</given-names></name> <name><surname>Schneewind</surname> <given-names>O.</given-names></name></person-group> (<year>2007</year>). <article-title>Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in <italic>Staphylococcus aureus</italic> pneumonia</article-title>. <source>Nat. Med</source>. <volume>13</volume>, <fpage>1405</fpage>&#x02013;<lpage>1406</lpage>. <pub-id pub-id-type="doi">10.1038/nm1207-1405</pub-id><pub-id pub-id-type="pmid">18064027</pub-id></citation>
</ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calcutt</surname> <given-names>M. J.</given-names></name> <name><surname>Lavrrar</surname> <given-names>J. L.</given-names></name> <name><surname>Wise</surname> <given-names>K. S.</given-names></name></person-group> (<year>1999</year>). <article-title>IS1630 of <italic>Mycoplasma fermentans</italic>, a novel IS30-type insertion element that targets and duplicates inverted repeats of variable length and sequence during insertion</article-title>. <source>J. Bacteriol</source>. <volume>181</volume>, <fpage>7597</fpage>&#x02013;<lpage>7607</lpage>. <pub-id pub-id-type="pmid">10601219</pub-id></citation>
</ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cassat</surname> <given-names>J. E.</given-names></name> <name><surname>Dunman</surname> <given-names>P. M.</given-names></name> <name><surname>McAleese</surname> <given-names>F.</given-names></name> <name><surname>Murphy</surname> <given-names>E.</given-names></name> <name><surname>Projan</surname> <given-names>S. J.</given-names></name> <name><surname>Smeltzer</surname> <given-names>M. S.</given-names></name></person-group> (<year>2005</year>). <article-title>Comparative genomics of <italic>Staphylococcus aureus</italic> Musculoskeletal isolates</article-title>. <source>J. Bacteriol</source>. <volume>187</volume>, <fpage>576</fpage>&#x02013;<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1128/JB.187.2.576-592.2005</pub-id><pub-id pub-id-type="pmid">15629929</pub-id></citation>
</ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Charpentier</surname> <given-names>E.</given-names></name> <name><surname>Anton</surname> <given-names>A. I.</given-names></name> <name><surname>Barry</surname> <given-names>P.</given-names></name> <name><surname>Alfonso</surname> <given-names>B.</given-names></name> <name><surname>Fang</surname> <given-names>Y.</given-names></name> <name><surname>Novick</surname> <given-names>R. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Novel cassette-based shuttle vector system for Gram-positive bacteria</article-title>. <source>Appl. Environ. Microbiol</source>. <volume>70</volume>, <fpage>6076</fpage>&#x02013;<lpage>6085</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.70.10.6076-6085.2004</pub-id><pub-id pub-id-type="pmid">15466553</pub-id></citation>
</ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Z.</given-names></name> <name><surname>Luong</surname> <given-names>T. T.</given-names></name> <name><surname>Lee</surname> <given-names>C. Y.</given-names></name></person-group> (<year>2007</year>). <article-title>The <italic>sbcDC</italic> locus mediates repression of type 5 capsule production as part of the SOS response in <italic>Staphylococcus aureus</italic></article-title>. <source>J. Bacteriol</source>. <volume>189</volume>, <fpage>7343</fpage>&#x02013;<lpage>7350</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01079-07</pub-id><pub-id pub-id-type="pmid">17704228</pub-id></citation>
</ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>M. C.</given-names></name> <name><surname>Melish</surname> <given-names>M. E.</given-names></name> <name><surname>James</surname> <given-names>J. F.</given-names></name></person-group> (<year>1985</year>). <article-title>Tryptophan auxotypy associated with <italic>Staphylococcus aureus</italic> that produce toxic-shock-syndrome toxin</article-title>. <source>J. Infect. Dis</source>. <volume>151</volume>, <fpage>1157</fpage>&#x02013;<lpage>1158</lpage>. <pub-id pub-id-type="pmid">3998511</pub-id></citation>
</ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname> <given-names>S. R.</given-names></name> <name><surname>Brummell</surname> <given-names>K. J.</given-names></name> <name><surname>Horsburgh</surname> <given-names>M. J.</given-names></name> <name><surname>McDowell</surname> <given-names>P. W.</given-names></name> <name><surname>Mohamad</surname> <given-names>S. A.</given-names></name> <name><surname>Stapleton</surname> <given-names>M. R.</given-names></name> <name><surname>Acevedo</surname> <given-names>J.</given-names></name> <name><surname>Read</surname> <given-names>R. C.</given-names></name> <name><surname>Day</surname> <given-names>N. P.</given-names></name> <name><surname>Peacock</surname> <given-names>S. J.</given-names></name> <name><surname>Mond</surname> <given-names>J. J.</given-names></name> <name><surname>Kokai-Kun</surname> <given-names>J. F.</given-names></name> <name><surname>Foster</surname> <given-names>S. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Identification of in vivo-expressed antigens of <italic>Staphylococcus aureus</italic> and their use in vaccinations for protection against nasal carriage</article-title>. <source>J. Infect. Dis</source>. <volume>193</volume>, <fpage>1098</fpage>&#x02013;<lpage>1108</lpage>. <pub-id pub-id-type="doi">10.1086/501471</pub-id><pub-id pub-id-type="pmid">16544250</pub-id></citation>
</ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Connelly</surname> <given-names>J. C.</given-names></name> <name><surname>Kirkham</surname> <given-names>L. A.</given-names></name> <name><surname>Leach</surname> <given-names>D. R.</given-names></name></person-group> (<year>1998</year>). <article-title>The SbcCD nuclease of <italic>Escherichia coli</italic> is a structural maintenance of chromosomes (SMC) family protein that cleaves hairpin DNA</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>95</volume>, <fpage>7969</fpage>&#x02013;<lpage>7974</lpage>. <pub-id pub-id-type="pmid">9653124</pub-id></citation>
</ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>R. A.</given-names></name> <name><surname>Conquest</surname> <given-names>C.</given-names></name> <name><surname>Mallaghan</surname> <given-names>C.</given-names></name> <name><surname>Marples</surname> <given-names>R. R.</given-names></name></person-group> (<year>1995</year>). <article-title>A major outbreak of methicillin-resistant <italic>Staphylococcus aureus</italic> caused by a new phage-type (EMRSA-16)</article-title>. <source>J. Hosp. Infect</source>. <volume>29</volume>, <fpage>87</fpage>&#x02013;<lpage>106</lpage>. <pub-id pub-id-type="pmid">7759837</pub-id></citation>
</ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname> <given-names>C.</given-names></name> <name><surname>Wang</surname> <given-names>B.</given-names></name> <name><surname>Moran</surname> <given-names>N.</given-names></name> <name><surname>Ochman</surname> <given-names>H.</given-names></name></person-group> (<year>2003</year>). <article-title>Loss of DNA recombinational repair enzymes in the initial stages of genome degeneration</article-title>. <source>Mol. Biol. Evol</source>. <volume>20</volume>, <fpage>1188</fpage>&#x02013;<lpage>1194</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msg138</pub-id><pub-id pub-id-type="pmid">12777518</pub-id></citation>
</ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dalrymple</surname> <given-names>B.</given-names></name></person-group> (<year>1987</year>). <article-title>Novel rearrangements of IS30 carrying plasmids leading to the reactivation of gene expression</article-title>. <source>Mol. Gen. Genet</source>. <volume>207</volume>, <fpage>413</fpage>&#x02013;<lpage>420</lpage>. <pub-id pub-id-type="pmid">3039299</pub-id></citation>
</ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Darmon</surname> <given-names>E.</given-names></name> <name><surname>Eykelenboom</surname> <given-names>J. K.</given-names></name> <name><surname>Lincker</surname> <given-names>F.</given-names></name> <name><surname>Jones</surname> <given-names>L. H.</given-names></name> <name><surname>White</surname> <given-names>M.</given-names></name> <name><surname>Okely</surname> <given-names>E.</given-names></name> <name><surname>Blackwood</surname> <given-names>J. K.</given-names></name> <name><surname>Leach</surname> <given-names>D. R.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>E. coli</italic> SbcCD and RecA control chromosomal rearrangement induced by an interrupted palindrome</article-title>. <source>Mol. Cell</source> <volume>39</volume>, <fpage>59</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2010.06.011</pub-id><pub-id pub-id-type="pmid">20603075</pub-id></citation>
</ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeLeo</surname> <given-names>F. R.</given-names></name> <name><surname>Kennedy</surname> <given-names>A. D.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Bubeck Wardenburg</surname> <given-names>J.</given-names></name> <name><surname>Kobayashi</surname> <given-names>S. D.</given-names></name> <name><surname>Mathema</surname> <given-names>B.</given-names></name> <name><surname>Braughton</surname> <given-names>K. R.</given-names></name> <name><surname>Whitney</surname> <given-names>A. R.</given-names></name> <name><surname>Villaruz</surname> <given-names>A. E.</given-names></name> <name><surname>Martens</surname> <given-names>C. A.</given-names></name> <name><surname>Porcella</surname> <given-names>S. F.</given-names></name> <name><surname>McGavin</surname> <given-names>M. J.</given-names></name> <name><surname>Otto</surname> <given-names>M.</given-names></name> <name><surname>Musser</surname> <given-names>J. M.</given-names></name> <name><surname>Kreiswirth</surname> <given-names>B. N.</given-names></name></person-group> (<year>2011</year>). <article-title>Molecular differentiation of historic phage-type 80/81 and contemporary epidemic <italic>Staphylococcus aureus</italic></article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>108</volume>, <fpage>18091</fpage>&#x02013;<lpage>18096</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1111084108</pub-id><pub-id pub-id-type="pmid">22025717</pub-id></citation>
</ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delorme</surname> <given-names>C.</given-names></name> <name><surname>Godon</surname> <given-names>J. J.</given-names></name> <name><surname>Ehrlich</surname> <given-names>S. D.</given-names></name> <name><surname>Renault</surname> <given-names>P.</given-names></name></person-group> (<year>1993</year>). <article-title>Gene inactivation in <italic>Lactococcus lactis</italic>: histidine biosynthesis</article-title>. <source>J. Bacteriol</source>. <volume>175</volume>, <fpage>4391</fpage>&#x02013;<lpage>4399</lpage>. <pub-id pub-id-type="pmid">7687248</pub-id></citation>
</ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doolittle</surname> <given-names>W. F.</given-names></name> <name><surname>Kirkwood</surname> <given-names>T. B.</given-names></name> <name><surname>Dempster</surname> <given-names>M. A.</given-names></name></person-group> (<year>1984</year>). <article-title>Selfish DNAs with self-restraint</article-title>. <source>Nature</source> <volume>307</volume>, <fpage>501</fpage>&#x02013;<lpage>502</lpage>. <pub-id pub-id-type="pmid">6320009</pub-id></citation>
</ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Enright</surname> <given-names>M. C.</given-names></name> <name><surname>Day</surname> <given-names>N. P.</given-names></name> <name><surname>Davies</surname> <given-names>C. E.</given-names></name> <name><surname>Peacock</surname> <given-names>S. J.</given-names></name> <name><surname>Spratt</surname> <given-names>B. G.</given-names></name></person-group> (<year>2000</year>). <article-title>Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of <italic>Staphylococcus aureus</italic></article-title>. <source>J. Clin. Microbiol</source>. <volume>38</volume>, <fpage>1008</fpage>&#x02013;<lpage>1015</lpage>. <pub-id pub-id-type="pmid">10698988</pub-id></citation>
</ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eykelenboom</surname> <given-names>J. K.</given-names></name> <name><surname>Blackwood</surname> <given-names>J. K.</given-names></name> <name><surname>Okely</surname> <given-names>E.</given-names></name> <name><surname>Leach</surname> <given-names>D. R.</given-names></name></person-group> (<year>2008</year>). <article-title>SbcCD causes a double-strand break at a DNA palindrome in the <italic>Escherichia coli</italic> chromosome</article-title>. <source>Mol. Cell</source> <volume>29</volume>, <fpage>644</fpage>&#x02013;<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2007.12.020</pub-id><pub-id pub-id-type="pmid">18342610</pub-id></citation>
</ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fehlner-Gardiner</surname> <given-names>C.</given-names></name> <name><surname>Roshick</surname> <given-names>C.</given-names></name> <name><surname>Carlson</surname> <given-names>J. H.</given-names></name> <name><surname>Hughes</surname> <given-names>S.</given-names></name> <name><surname>Belland</surname> <given-names>R. J.</given-names></name> <name><surname>Caldwell</surname> <given-names>H. D.</given-names></name> <name><surname>McClarty</surname> <given-names>G.</given-names></name></person-group> (<year>2002</year>). <article-title>Molecular basis defining human <italic>Chlamydia trachomatis</italic> tissue tropism. A possible role for tryptophan synthase</article-title>. <source>J. Biol. Chem</source>. <volume>277</volume>, <fpage>26893</fpage>&#x02013;<lpage>26903</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M203937200</pub-id><pub-id pub-id-type="pmid">12011099</pub-id></citation>
</ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feil</surname> <given-names>E. J.</given-names></name> <name><surname>Cooper</surname> <given-names>J. E.</given-names></name> <name><surname>Grundmann</surname> <given-names>H.</given-names></name> <name><surname>Robinson</surname> <given-names>D. A.</given-names></name> <name><surname>Enright</surname> <given-names>M. C.</given-names></name> <name><surname>Berendt</surname> <given-names>T.</given-names></name> <name><surname>Peacock</surname> <given-names>S. J.</given-names></name> <name><surname>Smith</surname> <given-names>J. M.</given-names></name> <name><surname>Murphy</surname> <given-names>M.</given-names></name> <name><surname>Spratt</surname> <given-names>B. G.</given-names></name> <name><surname>Moore</surname> <given-names>C. E.</given-names></name> <name><surname>Day</surname> <given-names>N. P.</given-names></name></person-group> (<year>2003</year>). <article-title>How clonal is <italic>Staphylococcus aureus</italic>?</article-title> <source>J. Bacteriol</source>. <volume>185</volume>, <fpage>3307</fpage>&#x02013;<lpage>3316</lpage>. <pub-id pub-id-type="doi">10.1128/JB.185.11.3307-3316.2003</pub-id><pub-id pub-id-type="pmid">12754228</pub-id></citation>
</ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname> <given-names>T. J.</given-names></name></person-group> (<year>2004</year>). <article-title>The <italic>Staphylococcus aureus</italic> &#x0201C;superbug&#x0201D;</article-title>. <source>J. Clin. Invest</source>. <volume>114</volume>, <fpage>1693</fpage>&#x02013;<lpage>1696</lpage>. <pub-id pub-id-type="doi">10.1172/JCI23825</pub-id><pub-id pub-id-type="pmid">15599392</pub-id></citation>
</ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fowler</surname> <given-names>V. G. Jr.</given-names></name> <name><surname>Nelson</surname> <given-names>C. L.</given-names></name> <name><surname>McIntyre</surname> <given-names>L. M.</given-names></name> <name><surname>Kreiswirth</surname> <given-names>B. N.</given-names></name> <name><surname>Monk</surname> <given-names>A.</given-names></name> <name><surname>Archer</surname> <given-names>G. L.</given-names></name> <name><surname>Federspiel</surname> <given-names>J.</given-names></name> <name><surname>Naidich</surname> <given-names>S.</given-names></name> <name><surname>Remortel</surname> <given-names>B.</given-names></name> <name><surname>Rude</surname> <given-names>T.</given-names></name> <name><surname>Brown</surname> <given-names>P.</given-names></name> <name><surname>Reller</surname> <given-names>L. B.</given-names></name> <name><surname>Corey</surname> <given-names>G. R.</given-names></name> <name><surname>Gill</surname> <given-names>S. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Potential associations between hematogenous complications and bacterial genotype in <italic>Staphylococcus aureus</italic> infection</article-title>. <source>J. Infect. Dis</source>. <volume>196</volume>, <fpage>738</fpage>&#x02013;<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1086/520088</pub-id><pub-id pub-id-type="pmid">17674317</pub-id></citation>
</ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>Z.</given-names></name> <name><surname>Donegan</surname> <given-names>N. P.</given-names></name> <name><surname>Memmi</surname> <given-names>G.</given-names></name> <name><surname>Cheung</surname> <given-names>A. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Characterization of MazFSa, an endoribonuclease from <italic>Staphylococcus aureus</italic></article-title>. <source>J. Bacteriol</source>. <volume>189</volume>, <fpage>8871</fpage>&#x02013;<lpage>8879</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01272-07</pub-id><pub-id pub-id-type="pmid">17933891</pub-id></citation>
</ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Alvarez</surname> <given-names>L.</given-names></name> <name><surname>Holden</surname> <given-names>M. T.</given-names></name> <name><surname>Lindsay</surname> <given-names>H.</given-names></name> <name><surname>Webb</surname> <given-names>C. R.</given-names></name> <name><surname>Brown</surname> <given-names>D. F.</given-names></name> <name><surname>Curran</surname> <given-names>M. D.</given-names></name> <name><surname>Walpole</surname> <given-names>E.</given-names></name> <name><surname>Brooks</surname> <given-names>K.</given-names></name> <name><surname>Pickard</surname> <given-names>D. J.</given-names></name> <name><surname>Teale</surname> <given-names>C.</given-names></name> <name><surname>Parkhill</surname> <given-names>J.</given-names></name> <name><surname>Bentley</surname> <given-names>S. D.</given-names></name> <name><surname>Edwards</surname> <given-names>G. F.</given-names></name> <name><surname>Girvan</surname> <given-names>E. K.</given-names></name> <name><surname>Kearns</surname> <given-names>A. M.</given-names></name> <name><surname>Pichon</surname> <given-names>B.</given-names></name> <name><surname>Hill</surname> <given-names>R. L.</given-names></name> <name><surname>Larsen</surname> <given-names>A. R.</given-names></name> <name><surname>Skov</surname> <given-names>R. L.</given-names></name> <name><surname>Peacock</surname> <given-names>S. J.</given-names></name> <name><surname>Maskell</surname> <given-names>D. J.</given-names></name> <name><surname>Holmes</surname> <given-names>M. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Meticillin-resistant <italic>Staphylococcus aureus</italic> with a novel <italic>mecA</italic> homologue in human and bovine populations in the UK and Denmark: a descriptive study</article-title>. <source>Lancet Infect. Dis</source>. <volume>11</volume>, <fpage>595</fpage>&#x02013;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(11)70126-8</pub-id><pub-id pub-id-type="pmid">21641281</pub-id></citation>
</ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geiger</surname> <given-names>T.</given-names></name> <name><surname>Goerke</surname> <given-names>C.</given-names></name> <name><surname>Mainiero</surname> <given-names>M.</given-names></name> <name><surname>Kraus</surname> <given-names>D.</given-names></name> <name><surname>Wolz</surname> <given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>The virulence regulator Sae of <italic>Staphylococcus aureus</italic>: promoter activities and response to phagocytosis-related signals</article-title>. <source>J. Bacteriol</source>. <volume>190</volume>, <fpage>3419</fpage>&#x02013;<lpage>3428</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01927-07</pub-id><pub-id pub-id-type="pmid">18344360</pub-id></citation>
</ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gerdes</surname> <given-names>K.</given-names></name> <name><surname>Christensen</surname> <given-names>S. K.</given-names></name> <name><surname>Lobner-Olesen</surname> <given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Prokaryotic toxin-antitoxin stress response loci</article-title>. <source>Nat. Rev. Microbiol</source>. <volume>3</volume>, <fpage>371</fpage>&#x02013;<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro1147</pub-id><pub-id pub-id-type="pmid">15864262</pub-id></citation>
</ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gillaspy</surname> <given-names>A. F.</given-names></name> <name><surname>Hickmon</surname> <given-names>S. G.</given-names></name> <name><surname>Skinner</surname> <given-names>R. A.</given-names></name> <name><surname>Thomas</surname> <given-names>J. R.</given-names></name> <name><surname>Nelson</surname> <given-names>C. L.</given-names></name> <name><surname>Smeltzer</surname> <given-names>M. S.</given-names></name></person-group> (<year>1995</year>). <article-title>Role of the accessory gene regulator (<italic>agr</italic>) in pathogenesis of <italic>Staphylococcal osteomyelitis</italic></article-title>. <source>Infect. Immun</source>. <volume>63</volume>, <fpage>3373</fpage>&#x02013;<lpage>3380</lpage>. <pub-id pub-id-type="pmid">7642265</pub-id></citation>
</ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guinane</surname> <given-names>C. M.</given-names></name> <name><surname>Ben Zakour</surname> <given-names>N. L.</given-names></name> <name><surname>Tormo-Mas</surname> <given-names>M. A.</given-names></name> <name><surname>Weinert</surname> <given-names>L. A.</given-names></name> <name><surname>Lowder</surname> <given-names>B. V.</given-names></name> <name><surname>Cartwright</surname> <given-names>R. A.</given-names></name> <name><surname>Smyth</surname> <given-names>D. S.</given-names></name> <name><surname>Smyth</surname> <given-names>C. J.</given-names></name> <name><surname>Lindsay</surname> <given-names>J. A.</given-names></name> <name><surname>Gould</surname> <given-names>K. A.</given-names></name> <name><surname>Witney</surname> <given-names>A.</given-names></name> <name><surname>Hinds</surname> <given-names>J.</given-names></name> <name><surname>Bollback</surname> <given-names>J. P.</given-names></name> <name><surname>Rambaut</surname> <given-names>A.</given-names></name> <name><surname>Penades</surname> <given-names>J. R.</given-names></name> <name><surname>Fitzgerald</surname> <given-names>J. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Evolutionary genomics of <italic>Staphylococcus aureus</italic> reveals insights into the origin and molecular basis of ruminant host adaptation</article-title>. <source>Genome Biol. Evol</source>. <volume>2</volume>, <fpage>454</fpage>&#x02013;<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1093/gbe/evq031</pub-id><pub-id pub-id-type="pmid">20624747</pub-id></citation>
</ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Niu</surname> <given-names>G.</given-names></name> <name><surname>Shui</surname> <given-names>W.</given-names></name> <name><surname>Sun</surname> <given-names>Y.</given-names></name> <name><surname>Zhou</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Yang</surname> <given-names>C.</given-names></name> <name><surname>Lou</surname> <given-names>Z.</given-names></name> <name><surname>Rao</surname> <given-names>Z.</given-names></name></person-group> (<year>2011</year>). <article-title>A structural view of the antibiotic degradation enzyme NDM-1 from a superbug</article-title>. <source>Protein Cell</source> <volume>2</volume>, <fpage>384</fpage>&#x02013;<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1007/s13238-011-1055-9</pub-id><pub-id pub-id-type="pmid">21637961</pub-id></citation>
</ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gyenis</surname> <given-names>L.</given-names></name> <name><surname>Duncan</surname> <given-names>J. S.</given-names></name> <name><surname>Turowec</surname> <given-names>J. P.</given-names></name> <name><surname>Bretner</surname> <given-names>M.</given-names></name> <name><surname>Litchfield</surname> <given-names>D. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of as a substrate for CK2</article-title>. <source>J. Proteome Res</source>. <volume>10</volume>, <fpage>4887</fpage>&#x02013;<lpage>4901</lpage>. <pub-id pub-id-type="doi">10.1021/pr2008994</pub-id><pub-id pub-id-type="pmid">21936567</pub-id></citation>
</ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hassall</surname> <given-names>J. E.</given-names></name> <name><surname>Rountree</surname> <given-names>P. M.</given-names></name></person-group> (<year>1959</year>). <article-title>Staphylococcal septicaemia</article-title>. <source>Lancet</source> <volume>1</volume>, <fpage>213</fpage>&#x02013;<lpage>217</lpage>. <pub-id pub-id-type="pmid">13631970</pub-id></citation>
</ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herron-Olson</surname> <given-names>L.</given-names></name> <name><surname>Fitzgerald</surname> <given-names>J. R.</given-names></name> <name><surname>Musser</surname> <given-names>J. M.</given-names></name> <name><surname>Kapur</surname> <given-names>V.</given-names></name></person-group> (<year>2007</year>). <article-title>Molecular correlates of host Specialization in <italic>Staphylococcus aureus</italic></article-title>. <source>PLoS One</source> <volume>2</volume>:<fpage>e1120</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0001120</pub-id><pub-id pub-id-type="pmid">17971880</pub-id></citation>
</ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holden</surname> <given-names>M. T.</given-names></name> <name><surname>Feil</surname> <given-names>E. J.</given-names></name> <name><surname>Lindsay</surname> <given-names>J. A.</given-names></name> <name><surname>Peacock</surname> <given-names>S. J.</given-names></name> <name><surname>Day</surname> <given-names>N. P.</given-names></name> <name><surname>Enright</surname> <given-names>M. C.</given-names></name> <name><surname>Foster</surname> <given-names>T. J.</given-names></name> <name><surname>Moore</surname> <given-names>C. E.</given-names></name> <name><surname>Hurst</surname> <given-names>L.</given-names></name> <name><surname>Atkin</surname> <given-names>R.</given-names></name> <name><surname>Barron</surname> <given-names>A.</given-names></name> <name><surname>Bason</surname> <given-names>N.</given-names></name> <name><surname>Bentley</surname> <given-names>S. D.</given-names></name> <name><surname>Chillingworth</surname> <given-names>C.</given-names></name> <name><surname>Chillingworth</surname> <given-names>T.</given-names></name> <name><surname>Churcher</surname> <given-names>C.</given-names></name> <name><surname>Clark</surname> <given-names>L.</given-names></name> <name><surname>Corton</surname> <given-names>C.</given-names></name> <name><surname>Cronin</surname> <given-names>A.</given-names></name> <name><surname>Doggett</surname> <given-names>J.</given-names></name> <name><surname>Dowd</surname> <given-names>L.</given-names></name> <name><surname>Feltwell</surname> <given-names>T.</given-names></name> <name><surname>Hance</surname> <given-names>Z.</given-names></name> <name><surname>Harris</surname> <given-names>B.</given-names></name> <name><surname>Hauser</surname> <given-names>H.</given-names></name> <name><surname>Holroyd</surname> <given-names>S.</given-names></name> <name><surname>Jagels</surname> <given-names>K.</given-names></name> <name><surname>James</surname> <given-names>K. D.</given-names></name> <name><surname>Lennard</surname> <given-names>N.</given-names></name> <name><surname>Line</surname> <given-names>A.</given-names></name> <name><surname>Mayes</surname> <given-names>R.</given-names></name> <name><surname>Moule</surname> <given-names>S.</given-names></name> <name><surname>Mungall</surname> <given-names>K.</given-names></name> <name><surname>Ormond</surname> <given-names>D.</given-names></name> <name><surname>Quail</surname> <given-names>M. A.</given-names></name> <name><surname>Rabbinowitsch</surname> <given-names>E.</given-names></name> <name><surname>Rutherford</surname> <given-names>K.</given-names></name> <name><surname>Sanders</surname> <given-names>M.</given-names></name> <name><surname>Sharp</surname> <given-names>S.</given-names></name> <name><surname>Simmonds</surname> <given-names>M.</given-names></name> <name><surname>Stevens</surname> <given-names>K.</given-names></name> <name><surname>Whitehead</surname> <given-names>S.</given-names></name> <name><surname>Barrell</surname> <given-names>B. G.</given-names></name> <name><surname>Spratt</surname> <given-names>B. G.</given-names></name> <name><surname>Parkhill</surname> <given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Complete genomes of two clinical <italic>Staphylococcus aureus</italic> strains: evidence for the rapid evolution of virulence and drug resistance</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>101</volume>, <fpage>9786</fpage>&#x02013;<lpage>9791</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0402521101</pub-id><pub-id pub-id-type="pmid">15213324</pub-id></citation>
</ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holtfreter</surname> <given-names>S.</given-names></name> <name><surname>Grumann</surname> <given-names>D.</given-names></name> <name><surname>Schmudde</surname> <given-names>M.</given-names></name> <name><surname>Nguyen</surname> <given-names>H. T.</given-names></name> <name><surname>Eichler</surname> <given-names>P.</given-names></name> <name><surname>Strommenger</surname> <given-names>B.</given-names></name> <name><surname>Kopron</surname> <given-names>K.</given-names></name> <name><surname>Kolata</surname> <given-names>J.</given-names></name> <name><surname>Giedrys-Kalemba</surname> <given-names>S.</given-names></name> <name><surname>Steinmetz</surname> <given-names>I.</given-names></name> <name><surname>Witte</surname> <given-names>W.</given-names></name> <name><surname>Broker</surname> <given-names>B. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Clonal distribution of superantigen genes in clinical <italic>Staphylococcus aureus</italic> isolates</article-title>. <source>J. Clin. Microbiol</source>. <volume>45</volume>, <fpage>2669</fpage>&#x02013;<lpage>2680</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00204-07</pub-id><pub-id pub-id-type="pmid">17537946</pub-id></citation>
</ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname> <given-names>T.</given-names></name> <name><surname>Martin</surname> <given-names>W.</given-names></name> <name><surname>Nei</surname> <given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Acceleration of genomic evolution caused by enhanced mutation rate in endocellular symbionts</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>99</volume>, <fpage>12944</fpage>&#x02013;<lpage>12948</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.192449699</pub-id><pub-id pub-id-type="pmid">12235368</pub-id></citation>
</ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>A. P.</given-names></name> <name><surname>Aucken</surname> <given-names>H. M.</given-names></name> <name><surname>Cavendish</surname> <given-names>S.</given-names></name> <name><surname>Ganner</surname> <given-names>M.</given-names></name> <name><surname>Wale</surname> <given-names>M. C.</given-names></name> <name><surname>Warner</surname> <given-names>M.</given-names></name> <name><surname>Livermore</surname> <given-names>D. M.</given-names></name> <name><surname>Cookson</surname> <given-names>B. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS)</article-title>. <source>J. Antimicrob. Chemother</source>. <volume>48</volume>, <fpage>143</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="pmid">11418528</pub-id></citation>
</ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamada</surname> <given-names>K.</given-names></name> <name><surname>Hanaoka</surname> <given-names>F.</given-names></name></person-group> (<year>2005</year>). <article-title>Conformational change in the catalytic site of the ribonuclease YoeB toxin by YefM antitoxin</article-title>. <source>Mol. Cell</source> <volume>19</volume>, <fpage>497</fpage>&#x02013;<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2005.07.004</pub-id><pub-id pub-id-type="pmid">16109374</pub-id></citation>
</ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname> <given-names>A. D.</given-names></name> <name><surname>Bubeck Wardenburg</surname> <given-names>J.</given-names></name> <name><surname>Gardner</surname> <given-names>D. J.</given-names></name> <name><surname>Long</surname> <given-names>D.</given-names></name> <name><surname>Whitney</surname> <given-names>A. R.</given-names></name> <name><surname>Braughton</surname> <given-names>K. R.</given-names></name> <name><surname>Schneewind</surname> <given-names>O.</given-names></name> <name><surname>Deleo</surname> <given-names>F. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model</article-title>. <source>J. Infect. Dis</source>. <volume>202</volume>, <fpage>1050</fpage>&#x02013;<lpage>1058</lpage>. <pub-id pub-id-type="doi">10.1086/656043</pub-id><pub-id pub-id-type="pmid">20726702</pub-id></citation>
</ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname> <given-names>K. S.</given-names></name> <name><surname>Lee</surname> <given-names>J. Y.</given-names></name> <name><surname>Baek</surname> <given-names>J. Y.</given-names></name> <name><surname>Peck</surname> <given-names>K. R.</given-names></name> <name><surname>Rhee</surname> <given-names>J. Y.</given-names></name> <name><surname>Kwon</surname> <given-names>K. T.</given-names></name> <name><surname>Heo</surname> <given-names>S. T.</given-names></name> <name><surname>Ahn</surname> <given-names>K. M.</given-names></name> <name><surname>Song</surname> <given-names>J. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Characterization of <italic>Staphylococcus aureus</italic> nasal carriage from children attending an outpatient clinic in Seoul, Korea</article-title>. <source>Microb. Drug Resist</source>. <volume>14</volume>, <fpage>37</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1089/mdr.2008.0776</pub-id><pub-id pub-id-type="pmid">18346010</pub-id></citation>
</ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kreiswirth</surname> <given-names>B. N.</given-names></name> <name><surname>Projan</surname> <given-names>S. J.</given-names></name> <name><surname>Schlievert</surname> <given-names>P. M.</given-names></name> <name><surname>Novick</surname> <given-names>R. P.</given-names></name></person-group> (<year>1989</year>). <article-title>Toxic shock syndrome toxin 1 is encoded by a variable genetic element</article-title>. <source>Rev. Infect. Dis</source>. <volume>11(Suppl. 1)</volume>, <fpage>S83</fpage>&#x02013;<lpage>S88</lpage>. discussion S88&#x02013;S89. <pub-id pub-id-type="pmid">2564693</pub-id></citation>
</ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuehnert</surname> <given-names>M. J.</given-names></name> <name><surname>Kruszon-Moran</surname> <given-names>D.</given-names></name> <name><surname>Hill</surname> <given-names>H. A.</given-names></name> <name><surname>McQuillan</surname> <given-names>G.</given-names></name> <name><surname>McAllister</surname> <given-names>S. K.</given-names></name> <name><surname>Fosheim</surname> <given-names>G.</given-names></name> <name><surname>McDougal</surname> <given-names>L. K.</given-names></name> <name><surname>Chaitram</surname> <given-names>J.</given-names></name> <name><surname>Jensen</surname> <given-names>B.</given-names></name> <name><surname>Fridkin</surname> <given-names>S. K.</given-names></name> <name><surname>Killgore</surname> <given-names>G.</given-names></name> <name><surname>Tenover</surname> <given-names>F. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Prevalence of <italic>Staphylococcus aureus</italic> nasal colonization in the United States</article-title>, <fpage>2001</fpage>&#x02013;<lpage>2002.</lpage> <source>J. Infect. Dis</source>. <volume>193</volume>, <fpage>172</fpage>&#x02013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1086/499632</pub-id><pub-id pub-id-type="pmid">16362880</pub-id></citation>
</ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname> <given-names>M.</given-names></name> <name><surname>Ohta</surname> <given-names>T.</given-names></name> <name><surname>Uchiyama</surname> <given-names>I.</given-names></name> <name><surname>Baba</surname> <given-names>T.</given-names></name> <name><surname>Yuzawa</surname> <given-names>H.</given-names></name> <name><surname>Kobayashi</surname> <given-names>I.</given-names></name> <name><surname>Cui</surname> <given-names>L.</given-names></name> <name><surname>Oguchi</surname> <given-names>A.</given-names></name> <name><surname>Aoki</surname> <given-names>K.</given-names></name> <name><surname>Nagai</surname> <given-names>Y.</given-names></name> <name><surname>Lian</surname> <given-names>J.</given-names></name> <name><surname>Ito</surname> <given-names>T.</given-names></name> <name><surname>Kanamori</surname> <given-names>M.</given-names></name> <name><surname>Matsumaru</surname> <given-names>H.</given-names></name> <name><surname>Maruyama</surname> <given-names>A.</given-names></name> <name><surname>Murakami</surname> <given-names>H.</given-names></name> <name><surname>Hosoyama</surname> <given-names>A.</given-names></name> <name><surname>Mizutani-Ui</surname> <given-names>Y.</given-names></name> <name><surname>Takahashi</surname> <given-names>N. K.</given-names></name> <name><surname>Sawano</surname> <given-names>T.</given-names></name> <name><surname>Inoue</surname> <given-names>R.</given-names></name> <name><surname>Kaito</surname> <given-names>C.</given-names></name> <name><surname>Sekimizu</surname> <given-names>K.</given-names></name> <name><surname>Hirakawa</surname> <given-names>H.</given-names></name> <name><surname>Kuhara</surname> <given-names>S.</given-names></name> <name><surname>Goto</surname> <given-names>S.</given-names></name> <name><surname>Yabuzaki</surname> <given-names>J.</given-names></name> <name><surname>Kanehisa</surname> <given-names>M.</given-names></name> <name><surname>Yamashita</surname> <given-names>A.</given-names></name> <name><surname>Oshima</surname> <given-names>K.</given-names></name> <name><surname>Furuya</surname> <given-names>K.</given-names></name> <name><surname>Yoshino</surname> <given-names>C.</given-names></name> <name><surname>Shiba</surname> <given-names>T.</given-names></name> <name><surname>Hattori</surname> <given-names>M.</given-names></name> <name><surname>Ogasawara</surname> <given-names>N.</given-names></name> <name><surname>Hayashi</surname> <given-names>H.</given-names></name> <name><surname>Hiramatsu</surname> <given-names>K.</given-names></name></person-group> (<year>2001</year>). <article-title>Whole genome sequencing of meticillin-resistant <italic>Staphylococcus aureus</italic></article-title>. <source>Lancet</source> <volume>357</volume>, <fpage>1225</fpage>&#x02013;<lpage>1240</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(00)04403-2</pub-id><pub-id pub-id-type="pmid">11418146</pub-id></citation>
</ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname> <given-names>T.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Dubow</surname> <given-names>M.</given-names></name> <name><surname>Gros</surname> <given-names>P.</given-names></name> <name><surname>Pelletier</surname> <given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>The complete genomes and proteomes of 27 <italic>Staphylococcus aureus</italic> bacteriophages</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>102</volume>, <fpage>5174</fpage>&#x02013;<lpage>5179</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0501140102</pub-id><pub-id pub-id-type="pmid">15788529</pub-id></citation>
</ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Marechal</surname> <given-names>C.</given-names></name> <name><surname>Hernandez</surname> <given-names>D.</given-names></name> <name><surname>Schrenzel</surname> <given-names>J.</given-names></name> <name><surname>Even</surname> <given-names>S.</given-names></name> <name><surname>Berkova</surname> <given-names>N.</given-names></name> <name><surname>Thiery</surname> <given-names>R.</given-names></name> <name><surname>Vautor</surname> <given-names>E.</given-names></name> <name><surname>Fitzgerald</surname> <given-names>J. R.</given-names></name> <name><surname>Francois</surname> <given-names>P.</given-names></name> <name><surname>Le Loir</surname> <given-names>Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Genome sequences of two <italic>Staphylococcus aureus</italic> ovine strains that induce severe (strain O11) and mild (strain O46) mastitis</article-title>. <source>J. Bacteriol</source>. <volume>193</volume>, <fpage>2353</fpage>&#x02013;<lpage>2354</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00045-11</pub-id><pub-id pub-id-type="pmid">21398544</pub-id></citation>
</ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname> <given-names>D. Y.</given-names></name> <name><surname>Meissner</surname> <given-names>H. C.</given-names></name> <name><surname>Fulton</surname> <given-names>D. R.</given-names></name> <name><surname>Murray</surname> <given-names>D. L.</given-names></name> <name><surname>Kotzin</surname> <given-names>B. L.</given-names></name> <name><surname>Schlievert</surname> <given-names>P. M.</given-names></name></person-group> (<year>1993</year>). <article-title>Toxic shock syndrome toxin-secreting <italic>Staphylococcus aureus</italic> in Kawasaki syndrome</article-title>. <source>Lancet</source> <volume>342</volume>, <fpage>1385</fpage>&#x02013;<lpage>1388</lpage>. <pub-id pub-id-type="pmid">7901681</pub-id></citation>
</ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Stevens</surname> <given-names>D. L.</given-names></name> <name><surname>Hamilton</surname> <given-names>S. M.</given-names></name> <name><surname>Parimon</surname> <given-names>T.</given-names></name> <name><surname>Ma</surname> <given-names>Y.</given-names></name> <name><surname>Kearns</surname> <given-names>A. M.</given-names></name> <name><surname>Ellis</surname> <given-names>R. W.</given-names></name> <name><surname>Bryant</surname> <given-names>A. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Fatal <italic>S. aureus</italic> hemorrhagic pneumonia: genetic analysis of a unique clinical isolate producing both PVL and TSST-1</article-title>. <source>PLoS One</source> <volume>6</volume>:<fpage>e27246</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0027246</pub-id><pub-id pub-id-type="pmid">22110621</pub-id></citation>
</ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>Y. C.</given-names></name> <name><surname>Anderson</surname> <given-names>M. J.</given-names></name> <name><surname>Kohler</surname> <given-names>P. L.</given-names></name> <name><surname>Strandberg</surname> <given-names>K. L.</given-names></name> <name><surname>Olson</surname> <given-names>M. E.</given-names></name> <name><surname>Horswill</surname> <given-names>A. R.</given-names></name> <name><surname>Schlievert</surname> <given-names>P. M.</given-names></name> <name><surname>Peterson</surname> <given-names>M. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Proinflammatory exoprotein characterization of toxic shock syndrome <italic>Staphylococcus aureus</italic></article-title>. <source>Biochemistry</source> <volume>50</volume>, <fpage>7157</fpage>&#x02013;<lpage>7167</lpage>. <pub-id pub-id-type="doi">10.1021/bi200435n</pub-id><pub-id pub-id-type="pmid">21749039</pub-id></citation>
</ref>
<ref id="B52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindsay</surname> <given-names>J. A.</given-names></name> <name><surname>Holden</surname> <given-names>M. T.</given-names></name></person-group> (<year>2004</year>). <article-title><italic>Staphylococcus aureus</italic>: superbug, super genome?</article-title> <source>Trends Microbiol</source>. <volume>12</volume>, <fpage>378</fpage>&#x02013;<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2004.06.004</pub-id><pub-id pub-id-type="pmid">15276614</pub-id></citation>
</ref>
<ref id="B53">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindsay</surname> <given-names>J. A.</given-names></name> <name><surname>Ruzin</surname> <given-names>A.</given-names></name> <name><surname>Ross</surname> <given-names>H. F.</given-names></name> <name><surname>Kurepina</surname> <given-names>N.</given-names></name> <name><surname>Novick</surname> <given-names>R. P.</given-names></name></person-group> (<year>1998</year>). <article-title>The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in <italic>Staphylococcus aureus</italic></article-title>. <source>Mol. Microbiol</source>. <volume>29</volume>, <fpage>527</fpage>&#x02013;<lpage>543</lpage>. <pub-id pub-id-type="pmid">9720870</pub-id></citation>
</ref>
<ref id="B54">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lowder</surname> <given-names>B. V.</given-names></name> <name><surname>Guinane</surname> <given-names>C. M.</given-names></name> <name><surname>Ben Zakour</surname> <given-names>N. L.</given-names></name> <name><surname>Weinert</surname> <given-names>L. A.</given-names></name> <name><surname>Conway-Morris</surname> <given-names>A.</given-names></name> <name><surname>Cartwright</surname> <given-names>R. A.</given-names></name> <name><surname>Simpson</surname> <given-names>A. J.</given-names></name> <name><surname>Rambaut</surname> <given-names>A.</given-names></name> <name><surname>Nubel</surname> <given-names>U.</given-names></name> <name><surname>Fitzgerald</surname> <given-names>J. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Recent human-to-poultry host jump, adaptation, and pandemic spread of <italic>Staphylococcus aureus</italic></article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>106</volume>, <fpage>19545</fpage>&#x02013;<lpage>19550</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0909285106</pub-id><pub-id pub-id-type="pmid">19884497</pub-id></citation>
</ref>
<ref id="B55">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lysnyansky</surname> <given-names>I.</given-names></name> <name><surname>Calcutt</surname> <given-names>M. J.</given-names></name> <name><surname>Ben-Barak</surname> <given-names>I.</given-names></name> <name><surname>Ron</surname> <given-names>Y.</given-names></name> <name><surname>Levisohn</surname> <given-names>S.</given-names></name> <name><surname>Methe</surname> <given-names>B. A.</given-names></name> <name><surname>Yogev</surname> <given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Molecular characterization of newly identified IS3, IS4 and IS30 insertion sequence-like elements in <italic>Mycoplasma bovis</italic> and their possible roles in genome plasticity</article-title>. <source>FEMS Microbiol. Lett</source>. <volume>294</volume>, <fpage>172</fpage>&#x02013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2009.01562.x</pub-id><pub-id pub-id-type="pmid">19416360</pub-id></citation>
</ref>
<ref id="B56">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mascarenhas</surname> <given-names>J.</given-names></name> <name><surname>Sanchez</surname> <given-names>H.</given-names></name> <name><surname>Tadesse</surname> <given-names>S.</given-names></name> <name><surname>Kidane</surname> <given-names>D.</given-names></name> <name><surname>Krisnamurthy</surname> <given-names>M.</given-names></name> <name><surname>Alonso</surname> <given-names>J. C.</given-names></name> <name><surname>Graumann</surname> <given-names>P. L.</given-names></name></person-group> (<year>2006</year>). <article-title><italic>Bacillus subtilis</italic> SbcC protein plays an important role in DNA inter-strand cross-link repair</article-title>. <source>BMC Mol. Biol</source>. <volume>7</volume>, <fpage>20</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2199-7-20</pub-id><pub-id pub-id-type="pmid">16780573</pub-id></citation>
</ref>
<ref id="B57">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McClarty</surname> <given-names>G.</given-names></name> <name><surname>Caldwell</surname> <given-names>H. D.</given-names></name> <name><surname>Nelson</surname> <given-names>D. E.</given-names></name></person-group> (<year>2007</year>). <article-title><italic>Chlamydial</italic> interferon gamma immune evasion influences infection tropism</article-title>. <source>Curr. Opin. Microbiol</source>. <volume>10</volume>, <fpage>47</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2006.12.003</pub-id><pub-id pub-id-type="pmid">17208039</pub-id></citation>
</ref>
<ref id="B58">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McDougal</surname> <given-names>L. K.</given-names></name> <name><surname>Steward</surname> <given-names>C. D.</given-names></name> <name><surname>Killgore</surname> <given-names>G. E.</given-names></name> <name><surname>Chaitram</surname> <given-names>J. M.</given-names></name> <name><surname>McAllister</surname> <given-names>S. K.</given-names></name> <name><surname>Tenover</surname> <given-names>F. C.</given-names></name></person-group> (<year>2003</year>). <article-title>Pulsed-field gel electrophoresis typing of oxacillin-resistant <italic>Staphylococcus aureus</italic> isolates from the United States: establishing a national database</article-title>. <source>J. Clin. Microbiol</source>. <volume>41</volume>, <fpage>5113</fpage>&#x02013;<lpage>5120</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.41.11.5113-5120.2003</pub-id><pub-id pub-id-type="pmid">14605147</pub-id></citation>
</ref>
<ref id="B59">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meinhart</surname> <given-names>A.</given-names></name> <name><surname>Alonso</surname> <given-names>J. C.</given-names></name> <name><surname>Strater</surname> <given-names>N.</given-names></name> <name><surname>Saenger</surname> <given-names>W.</given-names></name></person-group> (<year>2003</year>). <article-title>Crystal structure of the plasmid maintenance system epsilon/zeta: functional mechanism of toxin zeta and inactivation by epsilon 2 zeta 2 complex formation</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>100</volume>, <fpage>1661</fpage>&#x02013;<lpage>1666</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0434325100</pub-id><pub-id pub-id-type="pmid">12571357</pub-id></citation>
</ref>
<ref id="B60">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melles</surname> <given-names>D. C.</given-names></name> <name><surname>Gorkink</surname> <given-names>R. F.</given-names></name> <name><surname>Boelens</surname> <given-names>H. A.</given-names></name> <name><surname>Snijders</surname> <given-names>S. V.</given-names></name> <name><surname>Peeters</surname> <given-names>J. K.</given-names></name> <name><surname>Moorhouse</surname> <given-names>M. J.</given-names></name> <name><surname>van der Spek</surname> <given-names>P. J.</given-names></name> <name><surname>van Leeuwen</surname> <given-names>W. B.</given-names></name> <name><surname>Simons</surname> <given-names>G.</given-names></name> <name><surname>Verbrugh</surname> <given-names>H. A.</given-names></name> <name><surname>van Belkum</surname> <given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>Natural population dynamics and expansion of pathogenic clones of <italic>Staphylococcus aureus</italic></article-title>. <source>J. Clin. Invest</source> <volume>114</volume>, <fpage>1732</fpage>&#x02013;<lpage>1740</lpage>. <pub-id pub-id-type="doi">10.1172/JCI23083</pub-id><pub-id pub-id-type="pmid">15599398</pub-id></citation>
</ref>
<ref id="B61">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melles</surname> <given-names>D. C.</given-names></name> <name><surname>Tenover</surname> <given-names>F. C.</given-names></name> <name><surname>Kuehnert</surname> <given-names>M. J.</given-names></name> <name><surname>Witsenboer</surname> <given-names>H.</given-names></name> <name><surname>Peeters</surname> <given-names>J. K.</given-names></name> <name><surname>Verbrugh</surname> <given-names>H. A.</given-names></name> <name><surname>van Belkum</surname> <given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Overlapping population structures of nasal isolates of <italic>Staphylococcus aureus</italic> from healthy Dutch and American individuals</article-title>. <source>J. Clin. Microbiol</source>. <volume>46</volume>, <fpage>235</fpage>&#x02013;<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00887-07</pub-id><pub-id pub-id-type="pmid">17977984</pub-id></citation>
</ref>
<ref id="B62">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname> <given-names>P. C.</given-names></name> <name><surname>Lindsay</surname> <given-names>J. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Molecular characterisation of the dominant UK methicillin-resistant <italic>Staphylococcus aureus</italic> strains, EMRSA-15 and EMRSA-16</article-title>. <source>J. Med. Microbiol</source>. <volume>51</volume>, <fpage>516</fpage>&#x02013;<lpage>521</lpage>. <pub-id pub-id-type="pmid">12018660</pub-id></citation>
</ref>
<ref id="B63">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moran</surname> <given-names>N. A.</given-names></name> <name><surname>Plague</surname> <given-names>G. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Genomic changes following host restriction in bacteria</article-title>. <source>Curr. Opin. Genet. Dev</source>. <volume>14</volume>, <fpage>627</fpage>&#x02013;<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2004.09.003</pub-id><pub-id pub-id-type="pmid">15531157</pub-id></citation>
</ref>
<ref id="B64">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nickerson</surname> <given-names>N.</given-names></name> <name><surname>Ip</surname> <given-names>J.</given-names></name> <name><surname>Passos</surname> <given-names>D. T.</given-names></name> <name><surname>McGavin</surname> <given-names>M. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Comparison of Staphopain A (ScpA) and B (SspB) precursor activation mechanisms reveals unique secretion kinetics of proSspB (Staphopain B), and a different interaction with its cognate Staphostatin, SspC</article-title>. <source>Mol. Microbiol</source>. <volume>75</volume>, <fpage>161</fpage>&#x02013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.06974.x</pub-id><pub-id pub-id-type="pmid">19943908</pub-id></citation>
</ref>
<ref id="B65">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nienaber</surname> <given-names>J. J.</given-names></name> <name><surname>Sharma Kuinkel</surname> <given-names>B. K.</given-names></name> <name><surname>Clarke-Pearson</surname> <given-names>M.</given-names></name> <name><surname>Lamlertthon</surname> <given-names>S.</given-names></name> <name><surname>Park</surname> <given-names>L.</given-names></name> <name><surname>Rude</surname> <given-names>T. H.</given-names></name> <name><surname>Barriere</surname> <given-names>S.</given-names></name> <name><surname>Woods</surname> <given-names>C. W.</given-names></name> <name><surname>Chu</surname> <given-names>V. H.</given-names></name> <name><surname>Marin</surname> <given-names>M.</given-names></name> <name><surname>Bukovski</surname> <given-names>S.</given-names></name> <name><surname>Garcia</surname> <given-names>P.</given-names></name> <name><surname>Corey</surname> <given-names>G. R.</given-names></name> <name><surname>Korman</surname> <given-names>T.</given-names></name> <name><surname>Doco-Lecompte</surname> <given-names>T.</given-names></name> <name><surname>Murdoch</surname> <given-names>D. R.</given-names></name> <name><surname>Reller</surname> <given-names>L. B.</given-names></name> <name><surname>Fowler</surname> <given-names>V. G. Jr.</given-names></name></person-group> (<year>2011</year>). <article-title>Methicillin-susceptible <italic>Staphylococcus aureus</italic> endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins</article-title>. <source>J. Infect. Dis</source>. <volume>204</volume>, <fpage>704</fpage>&#x02013;<lpage>713</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jir389</pub-id><pub-id pub-id-type="pmid">21844296</pub-id></citation>
</ref>
<ref id="B66">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Novick</surname> <given-names>R. P.</given-names></name></person-group> (<year>1991</year>). <article-title>Genetic systems in staphylococci</article-title>. <source>Methods Enzymol</source>. <volume>204</volume>, <fpage>587</fpage>&#x02013;<lpage>636</lpage>. <pub-id pub-id-type="pmid">1658572</pub-id></citation>
</ref>
<ref id="B67">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Novick</surname> <given-names>R. P.</given-names></name> <name><surname>Subedi</surname> <given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>The SaPIs: mobile pathogenicity islands of Staphylococcus</article-title>. <source>Chem. Immunol. Allergy</source> <volume>93</volume>, <fpage>42</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1159/0000100857</pub-id><pub-id pub-id-type="pmid">17369699</pub-id></citation>
</ref>
<ref id="B68">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nygaard</surname> <given-names>T. K.</given-names></name> <name><surname>Pallister</surname> <given-names>K. B.</given-names></name> <name><surname>Ruzevich</surname> <given-names>P.</given-names></name> <name><surname>Griffith</surname> <given-names>S.</given-names></name> <name><surname>Vuong</surname> <given-names>C.</given-names></name> <name><surname>Voyich</surname> <given-names>J. M.</given-names></name></person-group> (<year>2010</year>). <article-title>SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesis</article-title>. <source>J. Infect. Dis</source>. <volume>201</volume>, <fpage>241</fpage>&#x02013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1086/649570</pub-id><pub-id pub-id-type="pmid">20001858</pub-id></citation>
</ref>
<ref id="B69">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pallen</surname> <given-names>M. J.</given-names></name> <name><surname>Wren</surname> <given-names>B. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Bacterial pathogenomics</article-title>. <source>Nature</source> <volume>449</volume>, <fpage>835</fpage>&#x02013;<lpage>842</lpage>. <pub-id pub-id-type="doi">10.1038/nature06248</pub-id><pub-id pub-id-type="pmid">17943120</pub-id></citation>
</ref>
<ref id="B70">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname> <given-names>D. P.</given-names></name> <name><surname>Gerdes</surname> <given-names>K.</given-names></name></person-group> (<year>2005</year>). <article-title>Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes</article-title>. <source>Nucleic Acids Res</source>. <volume>33</volume>, <fpage>966</fpage>&#x02013;<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki201</pub-id><pub-id pub-id-type="pmid">15718296</pub-id></citation>
</ref>
<ref id="B71">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname> <given-names>K.</given-names></name> <name><surname>Christensen</surname> <given-names>S. K.</given-names></name> <name><surname>Gerdes</surname> <given-names>K.</given-names></name></person-group> (<year>2002</year>). <article-title>Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins</article-title>. <source>Mol. Microbiol</source>. <volume>45</volume>, <fpage>501</fpage>&#x02013;<lpage>510</lpage>. <pub-id pub-id-type="pmid">12123459</pub-id></citation>
</ref>
<ref id="B72">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pilpa</surname> <given-names>R. M.</given-names></name> <name><surname>Fadeev</surname> <given-names>E. A.</given-names></name> <name><surname>Villareal</surname> <given-names>V. A.</given-names></name> <name><surname>Wong</surname> <given-names>M. L.</given-names></name> <name><surname>Phillips</surname> <given-names>M.</given-names></name> <name><surname>Clubb</surname> <given-names>R. T.</given-names></name></person-group> (<year>2006</year>). <article-title>Solution structure of the NEAT (NEAr Transporter) domain from IsdH/HarA: the human hemoglobin receptor in <italic>Staphylococcus aureus</italic></article-title>. <source>J. Mol. Biol</source>. <volume>360</volume>, <fpage>435</fpage>&#x02013;<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2006.05.019</pub-id><pub-id pub-id-type="pmid">16762363</pub-id></citation>
</ref>
<ref id="B73">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prere</surname> <given-names>M. F.</given-names></name> <name><surname>Chandler</surname> <given-names>M.</given-names></name> <name><surname>Fayet</surname> <given-names>O.</given-names></name></person-group> (<year>1990</year>). <article-title>Transposition in <italic>Shigella dysenteriae</italic>: isolation and analysis of IS911, a new member of the IS3 group of insertion sequences</article-title>. <source>J. Bacteriol</source>. <volume>172</volume>, <fpage>4090</fpage>&#x02013;<lpage>4099</lpage>. <pub-id pub-id-type="pmid">2163395</pub-id></citation>
</ref>
<ref id="B74">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>D. A.</given-names></name> <name><surname>Kearns</surname> <given-names>A. M.</given-names></name> <name><surname>Holmes</surname> <given-names>A.</given-names></name> <name><surname>Morrison</surname> <given-names>D.</given-names></name> <name><surname>Grundmann</surname> <given-names>H.</given-names></name> <name><surname>Edwards</surname> <given-names>G.</given-names></name> <name><surname>O&#x00027;Brien</surname> <given-names>F. G.</given-names></name> <name><surname>Tenover</surname> <given-names>F. C.</given-names></name> <name><surname>McDougal</surname> <given-names>L. K.</given-names></name> <name><surname>Monk</surname> <given-names>A. B.</given-names></name> <name><surname>Enright</surname> <given-names>M. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Re-emergence of early pandemic <italic>Staphylococcus aureus</italic> as a community-acquired meticillin-resistant clone</article-title>. <source>Lancet</source> <volume>365</volume>, <fpage>1256</fpage>&#x02013;<lpage>1258</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(05)74814-5</pub-id><pub-id pub-id-type="pmid">15811459</pub-id></citation>
</ref>
<ref id="B75">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rountree</surname> <given-names>P. M.</given-names></name> <name><surname>Beard</surname> <given-names>M. A.</given-names></name></person-group> (<year>1958</year>). <article-title>Further observations on infection with phage type 80 Staphylococci in Australia</article-title>. <source>Med. J. Aust</source>. <volume>45</volume>, <fpage>789</fpage>&#x02013;<lpage>795</lpage>. <pub-id pub-id-type="pmid">13612474</pub-id></citation>
</ref>
<ref id="B76">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruzin</surname> <given-names>A.</given-names></name> <name><surname>Lindsay</surname> <given-names>J.</given-names></name> <name><surname>Novick</surname> <given-names>R. P.</given-names></name></person-group> (<year>2001</year>). <article-title>Molecular genetics of SaPI1&#x02013;a mobile pathogenicity island in <italic>Staphylococcus aureus</italic></article-title>. <source>Mol. Microbiol</source>. <volume>41</volume>, <fpage>365</fpage>&#x02013;<lpage>377</lpage>. <pub-id pub-id-type="pmid">11489124</pub-id></citation>
</ref>
<ref id="B77">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schijffelen</surname> <given-names>M. J.</given-names></name> <name><surname>Boel</surname> <given-names>C. H.</given-names></name> <name><surname>van Strijp</surname> <given-names>J. A.</given-names></name> <name><surname>Fluit</surname> <given-names>A. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Whole genome analysis of a livestock-associated methicillin-resistant <italic>Staphylococcus aureus</italic> ST398 isolate from a case of human endocarditis</article-title>. <source>BMC Genomics</source> <volume>11</volume>, <fpage>376</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2164-11-376</pub-id><pub-id pub-id-type="pmid">20546576</pub-id></citation>
</ref>
<ref id="B78">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schlievert</surname> <given-names>P. M.</given-names></name> <name><surname>Blomster</surname> <given-names>D. A.</given-names></name></person-group> (<year>1983</year>). <article-title>Production of Staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors</article-title>. <source>J. Infect. Dis</source>. <volume>147</volume>, <fpage>236</fpage>&#x02013;<lpage>242</lpage>. <pub-id pub-id-type="pmid">6827140</pub-id></citation>
</ref>
<ref id="B79">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname> <given-names>Y.</given-names></name> <name><surname>Eisaki</surname> <given-names>N.</given-names></name> <name><surname>Ohtsubo</surname> <given-names>E.</given-names></name></person-group> (<year>1994</year>). <article-title>Translational control in production of transposase and in transposition of insertion sequence IS3</article-title>. <source>J. Mol. Biol</source>. <volume>235</volume>, <fpage>1406</fpage>&#x02013;<lpage>1420</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.1994.1097</pub-id><pub-id pub-id-type="pmid">8107082</pub-id></citation>
</ref>
<ref id="B80">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname> <given-names>Y.</given-names></name> <name><surname>Izumi</surname> <given-names>K.</given-names></name> <name><surname>Mizuno</surname> <given-names>T.</given-names></name> <name><surname>Ohtsubo</surname> <given-names>E.</given-names></name></person-group> (<year>1997</year>). <article-title>Inhibition of transpositional recombination by OrfA and OrfB proteins encoded by insertion sequence IS3</article-title>. <source>Genes Cells</source> <volume>2</volume>, <fpage>547</fpage>&#x02013;<lpage>557</lpage>. <pub-id pub-id-type="pmid">9413996</pub-id></citation>
</ref>
<ref id="B81">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seybold</surname> <given-names>U.</given-names></name> <name><surname>Kourbatova</surname> <given-names>E. V.</given-names></name> <name><surname>Johnson</surname> <given-names>J. G.</given-names></name> <name><surname>Halvosa</surname> <given-names>S. J.</given-names></name> <name><surname>Wang</surname> <given-names>Y. F.</given-names></name> <name><surname>King</surname> <given-names>M. D.</given-names></name> <name><surname>Ray</surname> <given-names>S. M.</given-names></name> <name><surname>Blumberg</surname> <given-names>H. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Emergence of community-associated methicillin-resistant <italic>Staphylococcus aureus</italic> USA300 genotype as a major cause of health care-associated blood stream infections</article-title>. <source>Clin. Infect. Dis</source>. <volume>42</volume>, <fpage>647</fpage>&#x02013;<lpage>656</lpage>. <pub-id pub-id-type="doi">10.1086/499815</pub-id><pub-id pub-id-type="pmid">16447110</pub-id></citation>
</ref>
<ref id="B82">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shopsin</surname> <given-names>B.</given-names></name> <name><surname>Gomez</surname> <given-names>M.</given-names></name> <name><surname>Montgomery</surname> <given-names>S. O.</given-names></name> <name><surname>Smith</surname> <given-names>D. H.</given-names></name> <name><surname>Waddington</surname> <given-names>M.</given-names></name> <name><surname>Dodge</surname> <given-names>D. E.</given-names></name> <name><surname>Bost</surname> <given-names>D. A.</given-names></name> <name><surname>Riehman</surname> <given-names>M.</given-names></name> <name><surname>Naidich</surname> <given-names>S.</given-names></name> <name><surname>Kreiswirth</surname> <given-names>B. N.</given-names></name></person-group> (<year>1999</year>). <article-title>Evaluation of protein A gene polymorphic region DNA sequencing for typing of <italic>Staphylococcus aureus</italic> strains</article-title>. <source>J. Clin. Microbiol</source>. <volume>37</volume>, <fpage>3556</fpage>&#x02013;<lpage>3563</lpage>. <pub-id pub-id-type="pmid">10523551</pub-id></citation>
</ref>
<ref id="B83">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ster</surname> <given-names>C.</given-names></name> <name><surname>Beaudoin</surname> <given-names>F.</given-names></name> <name><surname>Diarra</surname> <given-names>M. S.</given-names></name> <name><surname>Jacques</surname> <given-names>M.</given-names></name> <name><surname>Malouin</surname> <given-names>F.</given-names></name> <name><surname>Lacasse</surname> <given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Evaluation of some <italic>Staphylococcus aureus</italic> iron-regulated proteins as vaccine targets</article-title>. <source>Vet. Immunol. Immunopathol</source>. <volume>136</volume>, <fpage>311</fpage>&#x02013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetimm.2010.03.010</pub-id><pub-id pub-id-type="pmid">20416953</pub-id></citation>
</ref>
<ref id="B84">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanimoto</surname> <given-names>R. H.</given-names></name></person-group> (<year>1962</year>). <article-title>Observations on <italic>Staphylococcus aureus</italic> phage-type 80/81 Hawaii and its resistance to antibiotics</article-title>. <source>Hawaii Med. J</source>. <volume>21</volume>, <fpage>262</fpage>&#x02013;<lpage>265</lpage>. <pub-id pub-id-type="pmid">13919563</pub-id></citation>
</ref>
<ref id="B85">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Timmerman</surname> <given-names>K. P.</given-names></name> <name><surname>Tu</surname> <given-names>C. P.</given-names></name></person-group> (<year>1985</year>). <article-title>Complete sequence of IS3</article-title>. <source>Nucleic Acids Res</source>. <volume>13</volume>, <fpage>2127</fpage>&#x02013;<lpage>2139</lpage>. <pub-id pub-id-type="pmid">2987844</pub-id></citation>
</ref>
<ref id="B86">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsilibaris</surname> <given-names>V.</given-names></name> <name><surname>Maenhaut-Michel</surname> <given-names>G.</given-names></name> <name><surname>Mine</surname> <given-names>N.</given-names></name> <name><surname>van Melderen</surname> <given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>What is the benefit to <italic>Escherichia coli</italic> of having multiple toxin-antitoxin systems in its genome?</article-title> <source>J. Bacteriol</source>. <volume>189</volume>, <fpage>6101</fpage>&#x02013;<lpage>6108</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00527-07</pub-id><pub-id pub-id-type="pmid">17513477</pub-id></citation>
</ref>
<ref id="B87">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Voyich</surname> <given-names>J. M.</given-names></name> <name><surname>Vuong</surname> <given-names>C.</given-names></name> <name><surname>Dewald</surname> <given-names>M.</given-names></name> <name><surname>Nygaard</surname> <given-names>T. K.</given-names></name> <name><surname>Kocianova</surname> <given-names>S.</given-names></name> <name><surname>Griffith</surname> <given-names>S.</given-names></name> <name><surname>Jones</surname> <given-names>J.</given-names></name> <name><surname>Iverson</surname> <given-names>C.</given-names></name> <name><surname>Sturdevant</surname> <given-names>D. E.</given-names></name> <name><surname>Braughton</surname> <given-names>K. R.</given-names></name> <name><surname>Whitney</surname> <given-names>A. R.</given-names></name> <name><surname>Otto</surname> <given-names>M.</given-names></name> <name><surname>Deleo</surname> <given-names>F. R.</given-names></name></person-group> (<year>2009</year>). <article-title>The SaeR/S gene regulatory system is essential for innate immune evasion by <italic>Staphylococcus aureus</italic></article-title>. <source>J. Infect. Dis</source>. <volume>199</volume>, <fpage>1698</fpage>&#x02013;<lpage>1706</lpage>. <pub-id pub-id-type="doi">10.1086/598967</pub-id><pub-id pub-id-type="pmid">19374556</pub-id></citation>
</ref>
<ref id="B88">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wardenburg</surname> <given-names>J. B.</given-names></name> <name><surname>Schneewind</surname> <given-names>O.</given-names></name></person-group> (<year>2008</year>). <article-title>Vaccine protection against <italic>Staphylococcus aureus</italic> pneumonia</article-title>. <source>J. Exp. Med</source>. <volume>205</volume>, <fpage>287</fpage>&#x02013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20072208</pub-id><pub-id pub-id-type="pmid">18268041</pub-id></citation>
</ref>
<ref id="B89">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>J. R.</given-names></name> <name><surname>Talbot</surname> <given-names>E. C.</given-names></name> <name><surname>Maughan</surname> <given-names>E.</given-names></name></person-group> (<year>1959</year>). <article-title>Hospital outbreak of cross-infection due to <italic>Staphylococcus pyogenes</italic> phage type 80</article-title>. <source>Br. Med. J</source>. <volume>1</volume>, <fpage>1374</fpage>&#x02013;<lpage>1378</lpage>. <pub-id pub-id-type="pmid">13651738</pub-id></citation>
</ref>
<ref id="B90">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wormald</surname> <given-names>P. J.</given-names></name></person-group> (<year>1961</year>). <article-title>Multiple endemic substrains of <italic>Staphylococcus pyogenes</italic> phage type 80</article-title>. <source>Monatsschr. Unfallheilkd. Versicherungsmed</source>. <volume>20</volume>, <fpage>59</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="pmid">13786692</pub-id></citation>
</ref>
<ref id="B91">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname> <given-names>Y. Q.</given-names></name> <name><surname>Fowler</surname> <given-names>V. G.</given-names></name> <name><surname>Yeaman</surname> <given-names>M. R.</given-names></name> <name><surname>Perdreau-Remington</surname> <given-names>F.</given-names></name> <name><surname>Kreiswirth</surname> <given-names>B. N.</given-names></name> <name><surname>Bayer</surname> <given-names>A. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Phenotypic and genotypic characteristics of persistent methicillin-resistant <italic>Staphylococcus aureus</italic> bacteremia <italic>in vitro</italic> and in an experimental endocarditis model</article-title>. <source>J. Infect. Dis</source>. <volume>199</volume>, <fpage>201</fpage>&#x02013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1086/595738</pub-id><pub-id pub-id-type="pmid">19086913</pub-id></citation>
</ref>
</ref-list>
</back>
</article>